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THE ANTIBACTERIAL COMPOUND ASPERGILLIC ACID.
SUMMARY.
Aspergillic acid the antibacterial compound 
isolated by White in 1940 from culture filtrates of 
Aspergillus flavus was investigated by Dutcher and 
Wintersteiner who formulated it as (I) and its primary 
reduction product deoxyaspergillic acid as (II).
Deoxyaspergillic acid has been totally racemised by 
treatment with alkali at elevated temperature and the 
racemate is different from racemic 3-hydroxy-2:5-di- 
seci-butylpyrazine (II). By oxidation of aspergillic 
acid or deoxyaspergillic acid acetone is produced. 
Bromination of aspergillic acid followed by zinc and 
acetic acid reduction gives a 2:5-diketopiperazine. 
Hydrolysis of this diketopiperazine by hydrobromic 
acid gives a mixture of </.**amino-acids which has been 
resolved and the components identified as leucine and 
isoleucine (and alloisoleucine). These reactions do 
not accord with the structure of aspergillic acid 
proposed by Dutcher and Wintersteiner and it is now
OH 00CD
formulated as (III) or (IV). Growth of A. flavus on
a casein hydrolysate medium produces in addition to 
aspergillic acid another metabolite which was named 
flavacol, C^2^20^2* ^  was identified by synthesis
as 3-hydroxy-2:5-di-isobutylpyrazine. Kojic acid has
been produced by growth of A. flavus on a casein 
hydrolysate medium to which brown sugar was added.
Synthetic approaches to compounds related to 
aspergillic acid and deoxyaspergillic acid have been 
examined.
OH OH
(iv)(no
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INTRODUCTION
The phenomenon of microbial antagonism was 
recognised by Pasteur early in the development of micro­
biological science. That this antagonism could be 
manifest in the production by one micro-organism of a 
substance inhibitory to another was recognised. The 
specific antagonistic action of Pseudomonas aeruginosa 
upon various pathogenic bacteria was found to be due to 
production of an active heat-resistant substance. By 
enrichment methods there was obtained from culture 
filtrates of this organism a preparation designated 
pyocyanase (1) which was responsible for the activity. 
Subsequently it was shown that fungi as well as bacteria 
are able to elaborate antibacterial agents, penicillic 
acid, active against both Gram positive and Gram negative 
organisms being isolated from culture filtrates of 
Penicillium puberulum (2).
In 1929 Fleming observed that growth of the mould 
Penicillium notatum on liquid media produced a substance 
which he named penieillin, which was active against Gram 
positive organisms (3). The isolation of the labile 
aetive principle by Chain and Florey and co-workers and 
the demonstration of its remarkable chemotherapeutic 
properties (4) stimulated interest in this field of
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investigation. The outcome of the resulting intensive 
programme of research has been the recent discovery of 
a large number of antibacterial compounds, a few of 
which have been of clinical value.
The term antibiotic has been introduced by Waksman 
(5) to describe such antibacterial products and the term 
has been defined by Oxford (6). This last definition 
requires that the substance should show antibacterial 
activity at the arbitrary dilution of 1:20,000 against 
the selected test organism in vitro, that is in general, 
that the unenriched culture filtrate will have 
demonstrable antibacterial activity. The use of the 
term antibiotic is most generally limited to describing 
active metabolic products of bacteria, fungi and actino- 
mycetes•
The production of antibiotic substances is not a 
fundamental metabolic process of the organism but is 
largely determined by the nutritional supply. It has, 
further, been pointed out that antibiotic production is 
not necessarily a manifestation of microbial antagonism 
as an organism may produce a substance which is active 
against other organisms with which it does not normally 
compete for existence (6). Besides nutritional factors 
environmental factors also influence formation of anti­
biotics and a rationale for investigation has been
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evolved (7). Antibiotic production is not associated 
with strain specificity, different strains and even 
different genera producing the same substance, a fact 
which has resulted in a number of identical products 
bearing different names. Thus, for example, anhydro- 
3-hydroxymethylene-tetrahydro-Jf^pyrone-2-carboxylic acid 
has been variously named, patulin (8), clavacin (9), 
clavatin (10), claviformin (11), and expansin (12). On 
the other hand, under different conditions of growth the 
one species may produce more than one antibiotic.
By their mode of action antibiotic substances may 
be divided into two groups, those which are bacteriostatic 
in action and those which are bactericidal. The former 
although not destroying the organism, prevent, by 
interfering with some fundamental metabolic process, the 
proliferation of the organism. The latter are proto­
plasmic poisons and are destructive to animal as well as 
bacterial tissue. For an antibiotic to be useful, 
therefore, in the treatment of systemic infection its 
antibacterial action must be bacteriostatic (13).
Investigation of antibiotics necessitates methods 
of assaying the potency of culture filtrates and con­
centrates of culture filtrates. The most frequently 
used methods are based on the inhibition of growth and 
multiplication of the test organism. As the methods
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are arbitrary, uniformity of results between different 
methods can only be obtained by correlation using 
standards. In the Agar Streak method (14) different 
dilutions of the active substance are mixed with a 
standard volume of nutrient agar medium and the solidi­
fied agar streaked with a number of test organisms.
The dilution at which growth is inhibited under standard 
conditions gives a measure of the potency against the 
test organism. This method is generally used for 
investigation of antibiotic spectrum. In the Serial 
Dilution method (15) different volumes of the test 
medium are made up to a standard volume with different 
concentrations of the active substance. These solutions 
are inoculated with the test organism and incubated for 
a standard time. The highest dilution of the anti­
biotic giving complete inhibition of growth, as expressed 
by lack of turbidity of the medium, is taken as the end 
point. The Diffusion Cup method (16) consists of 
adding various dilutions of the active substance to the 
cup reservoir embedded in nutrient agar previously 
inoculated with the test organism. The active substance 
diffuses into the agar and sets up a zone of inhibition 
the diameter of which is a measure of the potency of the 
substance against the test organism.
Suggested classifications on the basis of chemical
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structure have been made (6, 17), however, antibiotics 
whose structure has subsequently been elucidated do not 
necessarily fall into any of these general classes. 
Increasing knowledge of the structure of antibiotics 
merely shows the diversity in chemical nature of these 
substances.
Among the moulds the genus Aspergillus has frequently 
been reported as producing antibiotic substances. 
Aspergillic acid with which this investigation is 
concerned is produced by a member of this genus, A.flavus.
ASPERGILLIC ACID.
Isolation.
In an examination of culture filtrates of 
different species of the mould Aspergillus grown on 
liquid media it was observed by White (18) in 1940 that 
the antibacterial activity was very variable. A 
particular species which was tentatively identified as 
A. flavus, grown in suitable nutrient liquid media gave 
a filtrate which was highly active against both Gram 
positive and Gram negative bacteria. Later White and 
Hill (19> 20) established the species as A. flavus and 
examined its growth characteristics. It grew well on 
a variety of media, but heavy growth occurred on some
- 6 -
media without development of antibacterial activity.
The most suitable medium consisted of tryptone or peptone 
and sodium chloride, the addition of glucose causing more 
rapid growth and giving higher antibacterial titres but 
increasing the difficulty of isolation. The filtrates 
were tested against a range of organisms, the titres 
being somewhat variable as was also the yield of active 
material. This inconsistency of results was due to 
variation of the mould, some of the variants being 
completely inactive. The active material because of 
its acidity was named aspergillic acid. The isolation 
procedure consisted of treating the culture filtrate at 
pH4 with absorbent charcoal. The air-dried charcoal 
was exhaustively extracted with ether, removal of the 
ether leaving a gum. Extraction of this gum with warm 
aqueous sodium hydrogen carbonate, followed by 
acidification of the extract gave crystalline aspergillic 
acid. The melting point of different samples fell 
within the range 84-96° although one sample had m.p.H6°. 
Aspergillic acid showed amphoteric properties and on 
analysis and molecular weight determination was ascribed 
the formula ci2H20^2N2* Tlie yield aspergillic acid 
averaged 5"*6mg ./litre of culture filtrate although it 
was obtained as high as 60mg./litre. Jones, Rake and
- 7 -
Hamre (21) showed that the strain of A. flavus employed 
by White and Hill consisted of a mixture of variants and 
isolated from it two highly active substrains. With 
these strains growth on a medium of 2% tryptone and 0*5% 
sodium chloride produced aspergillic acid in yields of 
120-250mg./litre and with 2-4% added brown sugar the 
yield was as high as 400mg./litre of culture filtrate. 
These workers developed a rapid assay method for activity 
of culture filtrates based on the inhibition of the 
bioluminescence of Photobacterium fischerii. This assay, 
which could be carried out in thirty minutes, showed that 
maximal activity was reached in about seven days and in 
about half that time when mycelial mats from previous 
batches were reflooded with fresh medium. Menzel, 
Wintersteiner and Rake (22) have also isolated aspergillic 
acid from culture filtrates of a strain of A. flavus grown 
on tryptone medium. Pure aspergillic acid according to 
these workers has m.p.93° and is optically active 
( [<*3o + 14°) can be distilled in steam or in vacuo 
without loss of biological activity. These workers 
showed further that on a culture medium of tryptone-brown 
sugar a related product C12H20°3N2 of f<*]o "^42°
was produced. This last product had only one tenth of 
the antibacterial activity of aspergillic acid. Menzel
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and co-workers expressed the opinion that the active 
culture filtrate obtained by Glister (23) from growth of 
an unspecified species of Aspergillus owed its activity 
to the presence of aspergillic acid. Bush et.al.(24) 
by growth of A. flavus, Link strain, on peptone-lactose 
medium obtained culture filtrates active against 
Mycobacterium tuberculosis in vitro. The active material 
was separated by fractional crystallisation into two 
components, one of m.p. 96*5-97«5° and the other m.p.118- 
121°. Both components had molecular weight 230 but the 
high melting one had only 75% of the activity of the other. 
The lower melting component was identified as aspergillic 
acid. The highest yield of aspergillic acid which has 
been recorded is on a medium of 2% yeast extract and 1% 
glycerol. On this medium surface culture of A. flavus 
gave aspergillic acid, 0OOmg./litre of culture filtrate 
(25).
Moulds of the genus Aspergillus have been recorded 
as producing a number of other antibiotic substances.
The production of penicillin - like antibacterials has 
been frequently reported (26, 27, 28, 29, 30). Waksman 
and co-workers (27) examining a number of strains of 
A. flavus observed that the activity of the culture 
filtrates resulted from the presence of two antibiotics,
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aspergillic acid and flavicin. Production of the former 
was favoured by surface culture and the latter by 
submerged culture with aeration. Clavatin isolated from 
culture filtrates of A. clavatus (10) has been shown to 
be identical with patulin (10) produced by Penicillium 
patulum (8) as is clavacin also produced by A. clavatus 
(31, 32). Helvolic acid active against Gram positive 
organisms has been isolated from cultures of A. fumigatus 
mutant Helvola Yuill (33) and is identical with fumigacin 
also isolated from cultures of A. fumigatus (34, 35). 
Gliotoxin has also been isolated from A. fumigatus (35, 
36) and aspergillin isolated from cultures of an 
unspecified species of Aspergillus (37) has been shown 
to be identical with gliotoxin (38). The pigment 
fumigatin is also produced by A. fumigatus (39).
Biological Properties of Aspergillic Acid.
Aspergillic acid acts as a powerful bactericide.
At dilutions of 1:25,000 it was bactericidal in twelve 
hours to five of the six organisms tested, and at 
1:50,000 dilution destroyed S. aureus in two hours (20). 
At much lower dilution it manifest bacteriostatic action, 
at a dilution of 1:400,000 having marked inhibitory 
effect on S. aureus (20). Aspergillic acid shows anti- 
tubercular activity in vitro (40, 24) and it is suggested
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(40) that the mechanism is the formation of a ferric 
complex, thus depriving the organism of available iron, 
this mechanism being supported by the observation that 
the presence of ferric ions interferes with the activity 
of aspergillic acid. It has been shown (41) that 
bismuth in a concentration which in itself causes no 
growth inhibition decreases considerably the quantity of 
aspergillic acid necessary for inhibiting completely the 
growth of S. aureus. In vitro activity is shown by 
aspergillic acid against the anaerobic gas gangrene 
organisms (42) and anti-spirochaetal activity is shown 
against the organism Treponema pallidum (43).
The use of aspergillic acid as a chemotherapeutic 
agent in treatment of systemic infection is limited by 
its relatively high toxicity to animals (20). In mice, 
repeated intraperitoneal injection of one third of the 
lethal dose did not give protection against infection 
with haemolytic Streptococci or Pneumococci although 
some protection against gonococcal infection was 
observed (20). Aspergillic acid therapy has been 
applied without success to a virus infection of mice, 
encephalomyelitis (44).
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Structure of Aspergillic Acid.
Initial investigation of the structure of aspergillic 
acid was made by Dutcher and Wintersteiner. The results 
of this investigation are summarised in a paper published 
by these authors in collaboration (45). later a more 
detailed account of the chemistry of aspergillic acid was 
reported by Dutcher (46, 47). Aspergillic acid
C12H20°2N2 is a weak acid (pKa 5*3) forming
copper and silver salts and giving a crystalline salt with
phenylhydrazine. The substance also shows weakly basic
properties as was demonstrated by the formation of a
hydrochloride in anhydrous medium and the formation of a
crystalline salt with 3:5-dinitrobenzoic acid.
Aspergillic acid gives an intense red colour on treatment
of a methanolic solution with ferric chloride, and, on
heating with copper chromite gives, with the loss of an
atom of oxygen, deoxyaspergillic acid cx2H200N2’ 80
optically active neutral compound m.p. 102°. These last
two reactions in conjunction with the formation of a
green copper salt suggested the presence of the hydroxamic
acid grouping —  N —  C —  # Reduction of aspergillic acid
I i 
OH 0
with hydriodic acid or hydrazine also resulted in 
formation of deoxyaspergillic acid. The stability of 
aspergillic acid to acid and alkaline hydrolysis
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indicated that the hydroxamic acid grouping could not be 
of simple aliphatic nature, since such groupings are 
readily hydrolysed. It was assumed, therefore, that 
the grouping formed part of a heterocyclic system. On 
the evidence of the similarity in ultra-violet light 
absorption spectra between deoxyaspergillic acid and 
hydroxypyrazine, the former was postulated as an alkyl- 
substituted hydroxypyrazine, the alkyl fragment having 
the asymmetry responsible for optical activity. 
Considering biogenetic possibilities in conjunction with 
the optical activity the hypothesis was adopted that the 
alkyl fragment consisted of two sec.-butyl groups 
symmetrically disposed in the pyrazine ring. Deoxy­
aspergillic acid was therefore formulated as d-3- 
hydroxy-2:5-di-sec.-butylpyrazine (V) and aspergillic 
acid as d-1-hydroxy-2-keto-3:6-di-sec.-butyl-1:2- 
dihydropyrazine (YI). These formulations appeared to
satisfy other properties of aspergillic acid and 
deoxyaspergillic acid. Bromination of aspergillic 
acid in aqueous solvents gave bromoaspergillic acid
(V) OH
(VO
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C12H19°2N2Br (VI1  ^8111(1 bromodeoxyaspergillic acid 
^12H19^N2Br (^III). The latter was also produced by 
direct bromination of deoxyaspergillic acid. That 
nuclear bromination in the unsubstituted position had 
taken place was demonstrated by the stability of bromo- 
aspergillic acid and bromodeoxyaspergillic acid to alkaline 
hydrolysis. The direct bromination of deoxyaspergillic 
acid gave, in addition to bromodeoxyaspergillic acid, a 
quinone-like compound, a 2:5-diketo-2:5-dihydropyrazine 
C^HigC^NgClX). Treatment of bromoaspergillic acid or 
bromodeoxyaspergillic acid with zinc in acetic acid 
solution gave in both cases the same compound 
C12H22°2N2 X^  ^which had the properties of a 2:5-diketo- 
piperazine and resembled DL-isoleucine anhydride. The 
same compound was also obtained by reduction of the 
diketodihydropyrazine (IX). Aspergillic acid and deoxy­
aspergillic acid were both reduced by zinc and acetic 
acid to the same compound, tetrahydrodeoxyaspergillic 
acid C^2H24^N2^X^^  which was also produced by catalytic 
hydrogenation of deoxyaspergillic acid. Total reduction 
of aspergillic acid was brought about by sodium and amyl 
alc-Ohol giving a piperazine base 0^2^25^  (XII) which 
resembled the piperazine base obtained by sodium and 
amyl alcohol reduction of EL-isoleucine anhydride.
These reactions are summarised schematically on p.l^ .
na
"H
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OH
^HC ■OH,CO
OH
OC
CO,CH;
H
(Xll) (x)
OV
/y
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Synthetic Compounds related to Aspergillic Acid and 
Deoxyaspergillic Acid.
Newbold and Spring (48) synthesised racemie 
3-hydroxy-2:5-di-sec.-butylpyrazine (XIII) as a preliminary 
step in the synthesis of aspergillic acid assuming the 
formulation of aspergillic acid by Dutcher & Wintersteiner 
(45). The route followed was
CHMeEt-COCl CH>f^  ■» CHMefrCOCHN, HCt. CHMeEt-COCHiCl
I
KO .CO,CHMeEhCOCHgN ^ C , , ^
JSaOH
^ X CHMcEt-N+NHx
CHMcEl
r > ^ X CHMeCh
(Xlli)
Kacemic 5-hydroxy-2:5-di-sec.-butylpyrazine differed 
from deoxyaspergillic acid. Newbold and Spring examined 
the ultra-violet absorption spectra of 3-hydroxy-2:5-di- 
£ec.-butylpyrazine, a number of other hydroxypyrazines, 
and deoxyaspergillic acid as supplied by Dr. 0.Wintersteiner. 
The results they obtained are tabulated. Dutcher and 
Wintersteiner (45) in their examination of the ultra­
violet light absorption of deoxyaspergillic acid observed
o
only the band at 3250A. Later, however, Dutcher (46) 
reported two-band absorption of similar location and 
intensity to that recorded by Newbold and Spring.
N, - 16 -
% *2 R3
V 0Am^A £ 1 Am2A £ 2
H H H - - 3160 4200
H Me Me . 2270 7600 3230 3600
Me Me Me 2295 7900 3360 7400
H CHMeEt CHMeEt 2285 9600 3220 10,000
Deoxyaspergillic Acid 2295 6700 3250 8000
Towards the end of the investigation carried out by 
the author, Lott and Shaw (49>50) published the results of 
examination of analogs of aspergillic acid as antibacterial 
agents. These workers prepared pyridine cyclic hydroxamic 
acid (XIV), a number of nuclear substituted pyridine cyclic 
hydroxamic acids, quinoline cyclic hydroxamic acid (XV) 
and a cyclic pyrimidine hydroxamic acid, N-hydroxy-426- 
dimethyl -2-pyrimidone (XVI).
Me
V. MeJ=0fcN ^  N" 'N'
OH Qcjv) ^ v )  OH^ (V()
These synthetic cyclic hydroxamic acids were tested against
t=o
Staphylococcus aureus, Klebsiella pneumoniae and Myco­
bacterium smegmatis and in general the activity was of 
the same order as aspergillic acid. Quinoline cyclic 
hydroxamic acid showed the greatest activity and the
- 17 -
pyrimidine cyclic hydroxamic acid showed the lowest 
antibacterial activity. Shaw and McDowell (51) have 
also prepared N-hydroxy-2-phenyl-4-benzylidene-5- 
imidazole (XIX) a five-membered ring analog of aspergillic 
acid. Treatment of 2-phenyl-4-benzylidene-5-oxazolone 
(XVII) with anhydrous methanolic hydroxylamine gave 
<*-benzamidocinnamohydroxamic acid (XVIII) which on 
heating with dilute hydrochloric acid cyclised to the 
hydroxamic acid (XEX).
CfcHj
0 1=0
(XVll)
OH
O
(XVIII) < )
I
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THEORETICAL.
This investigation was carried out as two main 
parts; firstly, degradative study with the object of 
reinvestigating the detailed structure of aspergillic 
acid, and secondly, model experiments on synthesis of 
compounds related to aspergillic acid and its primary 
degradation product deoxyaspergillic acid. Section I 
deals with investigations carried out on the natural 
product and Section II consists of model experiments, 
carried out in the light’of knowledge gained by 
degradation, having as their ultimate aim a synthesis 
of aspergillic acid and deoxyaspergillic acid.
SECTION I.
In the historical introduction the evidence which 
lead Dutcher and Wintersteiner (45) to formulate 
aspergillic acid as 1-hydroxy-2-keto-3:6-di-sec«-butyl- 
l:2-dihydropyrazine and deoxyaspergillic acid as 
5-hydroxy-2:5-di-sec.-butylpyrazine is summarised. The 
subsequent synthesis of this last compound by Newbold 
and Spring (48, p. is. ) did, in fact, confirm a very 
marked similarity between it and deoxyaspergillic acid 
although they differed in melting point. This difference 
could be considered to result from differences in 
optical properties between the optically active deoxy-
- 19 -
aspergillic acid and the racemic synthetic product. 
Newbold (52), however, drew attention to discrepancies 
in the ultra-violet absorption spectra of these two 
compounds, pointing out that, although the positions of 
the absorption maxima for deoxyaspergillic acid and 
3-hydroxy-2:5-di-sec.-butylpyrazine are identical, there 
is a considerable difference in the values of the 
respective molecular extinction coefficients. This 
difference in ultra-violet absorption spectra indicated 
that the non-identity of deoxyaspergillic acid with 
3-hydroxy-2:5-di-sec.-butylpyrazine was more fundamental 
than stereochemical, and stimulated this reinvestigation.
That the compound obtained by Newbold and Spring 
(48, p. 15 ) was in fact 3-hydroxy-2:5-di-sec.-butyl­
pyrazine was more rigorously confirmed by alternative 
syntheses by Baxter and Spring (53) and Newbold and 
Spring (54). In the synthesis of Baxter and Spring 
DL-isoleucine anhydride (XXI), prepared by refluxing 
DL-isoleucine (XX) with ethylene glycol, was treated 
with phosphoryl chloride. This reaction gave a mixture 
of 3-chloro-2:5-di-sec.-butylpyrazine (XXII) and 
3:6-dichloro-2:5-di-sec.-butylpyrazine (XXIII), separable 
by treatment with concentrated hydrochloric acid in 
which the former is soluble. Under intensive hydrolytic
- 20 -
conditions, with solid potassium hydroxide, 3-chloro- 
2:5-di-sec.-butylpyrazine was converted to 3-hydroxy- 
2:5-di-sec.-butylpyrazine (XXIV). The alternative 
synthesis by Newbold and Spring (54) started from 2:5-di- 
sec.-butylpyrazine (XXV). Treatment of this base, in
acetic acid solution, with hydrogen peroxide gave a 
mixture of the corresponding pyrazine-mono and di-N- 
oxides (XXVI and XXVII). The mono-N-oxide reacted with 
phosphoryl chloride to give 3-chioro-2:5-di-sec.-butyl­
pyrazine (XXII) which on alkaline hydrolysis gave 
3-hydroxy-2:5-di-sec.-butylpyrazine (XXIV). These 
reactions are summarised schematically on p.2i . These 
dissimilar syntheses indicated unequivocally the nature 
of the synthetic product and showed that a re-examination 
of the evidence for the structure of aspergillic acid was 
desirable•
Isolation of Natural Products.
Aspergillic acid has been prepared by a modification 
of the method of White and Hill (20) by growth of 
Aspergillus flavus on a casein hydrolysate-sodium 
chloride medium. The strain of A. flavus employed was 
the active strain isolated by Jones, Rake and Hamre (21) 
from White*s original mixed culture. As tryptone, an 
enzymic casein hydrolysate used by White and Hill (20)
- 21 -
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- 22 -
was not readily available in quantity, another commercial 
enzymic digest of casein, "Pronutrin", was used. The 
cultural characteristics of A. flavus on a "Pronutrin" 
containing medium were the same as on tryptone medium and 
aspergillic acid was produced equally well on either. 
Aspergillic acid is not, however, produced when an acidic 
digest of casein is substituted for tryptone (55). The 
yield of aspergillic acid, under the conditions employed,
250-300mg./litre of culture filtrate was rather lower than 
that obtained by Jones, Rake and Hamre (21) who used a 
similar medium containing added brown sugar. In 
attempting to increase the yield to the value, 350-400mg./ 
litre, reported by these workers, brown sugar was added to 
the basal medium. On this medium, however, the product 
could not be readily purified and after repeated 
crystallisation specimens were obtained melting as high as 
137°. White and Hill (20) having observed similar 
variation in the melting point suggested that this was due 
to the existence of polymorphic forms of aspergillic acid. 
Accordingly the entity of high melting point was at first 
considered to be such a variant. Analysis, however, 
showed that the product was richer in oxygen than is 
required by the formula 2* - Menzel, Wintersteiner
and Rake (22) have shown that A. flavus on a simple
- 23 -
tryptone-sodium chloride medium produces aspergillic 
acid, whereas, on the same medium to which brown sugar 
was added they obtained hydroxyaspergillic acid C12H20°3N2 
m.p. 149°. It is considered, therefore, that this high 
melting product, originally thought to be a polymorphic 
variant, is in fact a mixture of aspergillic acid and 
hydroxyaspergillic acid, although a satisfactory method 
for the isolation of this latter compound has not been 
evolved. After this preliminary work had been completed 
Dutcher (46) in an extensive report on aspergillic acid 
expressed the opinion that the high melting entities 
observed by White and Hill (20) and Bush et.al.(24) were, 
in fact, mixtures of aspergillic acid and hydroxy­
aspergillic acid.
Tke observed physical properties of aspergillic 
acid and the corresponding properties reported by 
Dutcher (46) are given in tabular form (p. 24 ).
Growth of A. flavus on a medium containing tryptone 
or "Pronutrin" and sodium chloride produced in addition 
to aspergillic acid another metabolite, which was named 
flavacol. In contradistinction to aspergillic acid 
which is soluble in sodium hydrogen carbonate solution, 
flavacol is insoluble but dissolves in aqueous sodium 
hydroxide, this difference being used as a basis for
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Physical Properties of Aspergillic Acid compared with 
those reported by Dutcher (46).
Properties
... . . . . . . . . . . ...I
Observed Dutcher (46)
,
Crystalline Radial Pale
j
Form. Clusters of Yellow
1
Yellow i Rods.
|
; 4
Needles. i
................i..  .. .
> Melting Point 97-99° 95°
»
1 Acidity (pka) 5 *95 5*3
ii
Optical
Rotation M i 7+13.3° [oc]f+ 12°(±3°)
(in ethanol)
|
Ultra-violet
Light
254oX,£=10,500 23508, £=10,800
Absorption
(in ethanol) 3280A,£= 8500 3300X,£= 9000
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separation. The yield of flavacol was extremely low, 
amounting to 25 mg. of crude material from 33 litres of 
culture filtrate, being partly due to the repeated 
crystallisation required for purification. Analysis 
indicated the molecular formula 2^20^2’ ^ a t  ^  
isomeric with deoxyaspergillic acid. Like deoxy­
aspergillic acid, flavacol dissolves in dilute mineral 
acid and aqueous alkali and does not give a colouration 
with ferric chloride reagent. In particular it resembles 
deoxyaspergillic acid and the isomeric 3-hydroxy-2:5-di­
sec, -butylpyrazine in its ultra-violet absorption 
spectrum, showing the characteristic two-band absorption 
associated with these compounds. The melting point 
144-146° is, however, much higher than that of either of 
these isomers. Flavacol was identified by synthesis as 
3-hydroxy-2:5-di-iso-butylpyrazine (p.56 ).
For the preparation of Mhigh melting aspergillic 
acid** a number of batches were cultivated of A. flavus 
grown on a medium to which brown sugar was added.
Although the cultural conditions were experimentally 
identical for each batch there was produced on one 
occasion, kojie acid (XXVIII) in addition to "high
26
melting aspergillic acid”. It was isolated from the
culture filtrate as described in the experimental section 
and identified by analysis, titration equivalent and 
comparison with an authentic specimen provided by 
Dr. A. H. Cook.
The production of kojic acid by fungi has been 
reported frequently. It was first recognised in cultures 
of A. oryzae (56) and was investigated by Yabuta, who, 
besides elucidating the structure (57) observed that it 
possesses slight antibacterial and antifungal activity 
(58). Since then it has been shown that many other 
species of Aspergilli produce kojic acid (59,60,61). 
Production of kojic acid by A. flavus has been reported 
on several occasions (62,63>64) on a variety of media, a 
strain having been isolated (63) which, grown on a 
glucose medium, converts 67% of the sugar assimilated 
into kojic acid. Cultural conditions for the production 
of this acid, however, are critical as it is readily 
metabolised further by the organism (62). This last 
factor may account for its isolation, in association with 
“high melting aspergillic acid", on but one occasion 
although conditions of growth were apparently identical
OH
for all batches.
Investigations not concerning the Pyrazine Nucleus.
Dutcher and Wintersteiner (45) in their investi­
gation of aspergillic acid stated that it could be 
converted to deoxyaspergillic acid by treatment with 
copper chromite or hydrazine, but did not give experi­
mental details. Early attempts to reduce aspergillic 
acid by heating with copper chromite gave in good yield 
copper aspergillate and not the desired deoxyaspergillic 
acid. Reduction of aspergillic acid with 100# 
hydrazine hydrate under conditions more drastic than 
subsequently described by Dutcher (46) gave deoxy­
aspergillic acid in 60# yield. When, instead of 100# 
hydrazine hydrate the more readily available 90# 
aqueous solution was used, ammonia was produced and the 
resulting deoxyaspergillic acid was partially racemised. 
Deoxyaspergillic acid m.p. 98-100° shows light
absorption in the ultra-violet consisting of two bands
o o
with maxima at 2280A (£=75oo) and at 3250A (£=8000).
These values are in close agreement with those obtained 
by Newbold and Spring (48) for a specimen of deoxy­
aspergillic acid supplied by Dr. 0. Wintersteiner.
The corresponding values (Newbold and Spring,, lac.cit.)
o
for 3-hydroxy-2:5-di-sec.-butylpyrazine, viz., 2285A
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o
(£=9600) and 3220A (£=10,000) are outwith experimental 
error and confirmed the significant discrepancy 
previously observed by Newbold (52).
Treatment of deoxyaspergillic acid with aqueous 
alkali at elevated temperature resulted in total 
racemisation, the racemate having m.p. 102-104°# 
Aspergillic acid upon similar treatment with alkali was 
not totally racemised. When similarly treated 3-hydroxy- 
2:5-di-sec.-butylpyrazine m.p. 122-123° was recovered 
unchanged. A mixture of 3-hydroxy-2:5-di-sec.-butyl­
pyrazine with racemic deoxyaspergillic acid showed a 
considerable depression in melting point. A consideration 
of the stereochemistry of 3-hydroxy-2:5-di-sec.-butyl­
pyrazine indicates the significance of these results.
Since 3-hydroxy-2:5-di-sec.-butylpyrazine has two 
asymmetric centres, there are 2 pairs of optical anti­
podes which can be represented conventionally by (XXIX) 
to (XXXII).
E t MeMeMe
OHHO
MeMe
Qcxix) (xx*) (XXXl) (XXXIl)
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Newbold (52) appreciating that two racemic forms of 
3-hydroxy-2:5-di-sec.-butylpyrazine are possible examined 
the synthetic material m.p* 122-123° for evidence of 
heterogeneity. Fractional crystallisation of this 
hydroxypyrazine showed it to be homogeneous. 3-Amino- 
2:5-di-sec.-butylpyrazine. the precursor of 3-hydroxy- 
2:5-di-sec.-butylpyrazine in the Newbold and Spring 
synthesis (p. ) was also examined for heterogeneity.
Extensive fractional crystallisation of the picrate of 
this base showed that this amino-compound was also a 
single racemate. Newbold (52) therefore considered the 
possibility that the non-identity of 3-hydroxy-2:5-di­
sec, -butylpyrazine with deoxyaspergillic acid was due 
to the latter belonging to the opposite optical series. 
Supposing this to be so, the fact that deoxyaspergillic 
acid was totally racemised indicates that the groups 
about both asymmetric centres are mobile, under the 
conditions of racemisation, and the racemate would 
therefore consist of a mixture of all four possible 
optical isomers. Likewise, treatment of 3-hydroxy- 
2:5-di-sec.-butylpyrazine with alkali at elevated 
temperature should give the same mixture of optical 
isomers. That this was not so, established con­
clusively that deoxyaspergillic acid is not a 3-hydroxy- 
2:5-di-sec.-butylpyrazine. The very definite evidence
- 30 -
for a hydroxypyrazine structure was recognised, however, 
and it was considered that Dutcher and Wintersteiner*s 
formulation of aspergillic acid most probably erred in 
the nature of the alkyl residue. Experiments were 
therefore developed having as their object the elucidation 
of the nature of the alkyl side-chain or chains.
C-Methyl values for a number of compounds of possible 
relation to deoxyaspergillic acid were determined by
Kuhn-Roth*s method and are
....
tabulated.
COMPOUND
C-Methyl Groups 
Theoretical
C-Methyl Groups 
Determined
Dl-Leucine 1 0*82
DL-isoLeucine 2 1-42
r-Deoxyaspergillic Acid 2-65
3-Hydroxy-2(5)-iso-butyl- 
5(2)-sec.-butylpyrazine 3
iI
2-71
3-Hydroxy-2:5-di-sec.- 
butylpyrazine 4 3-37
These results gave further confirmation of the non­
identity of racemic deoxyaspergillic acid with 3-hydroxy- 
2:5-di-sec.-butylpyrazine and ar.e in agreement with the 
values to be expected from the subsequently developed 
structure for deoxyaspergillic acid.
In alkaline solution deoxyaspergillic acid and 
racemic deoxyaspergillic acid both couple with benzene
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diazonium chloride solution to give in good yield the 
corresponding phenylazo-derivatives both of which have 
m.p, 188-190°. This reaction confirmed the presence of 
an unsubstituted position in the pyrazine nucleus, a 
conclusion deduced by Dutcher and Wintersteiner (45) on 
the evidence of formation of bromodeoxyaspergillic acid. 
The coupling of hydroxypyrazine has not been extensively 
investigated and the directive influence of alkyl 
substituents is not known. Gastaldi and Princivalle(65) 
prepared the 6-phenylazo-derivative of 3-hydroxy-2:5- 
dimethylpyrazine (XXXIV) and also the corresponding 
o- and p-tolylazo-derivatives. The same 6-phenylazo- 
derivative (XXXIV) has also been prepared (66) from 
3-hydroxy-2:5-dimethylpyrazine-6-carboxylic acid (XXXV).
MeV ^ , ° H
(XXXIII) (xxxiv) (xxxv)
by coupling with elimination of carbon dioxide.
Newbold (52) showed that the 6-phenylazo-derivative 
of 3-hydroxy-2:5-dimethylpyrazine (XXXVI,R=Me) is 
reduced in alkaline solution with sodium hydrosulphite 
to 3-amino-6-hydroxy-2:5-dimethylpyrazine (XXXVII,R=Me).
He attempted to convert this last compound to 3:6- 
dihydroxy-2:5-dimethylpyrazine (XXXVIII,ft= Me) by treatment 
with nitrous acid but was unable to isolate the desired
PhN*N
ne OH
HOOC
He OK
OH OH
(XXXVl) (XXXVII) (XXXVIII)
product. It would be expected that mild reduction of
a 2:5-dihydroxypyrazine would give the corresponding 
2:5-diketopiperazine. As such a route suggested a method 
of converting the phenylazo-derivative of deoxyaspergillic 
acid to a 2:5-diketopiperazine this reaction series was 
investigated. The reduction of 3-hydroxy-6-phenylazo- 
2:5-di-sec.-butylpyrazine (XXXVI,R=sec.-butyl) with sodium 
hydrosulphite was also investigated by Newbold (52) who 
failed to isolate 3-amino-6-hydroxy-2:5-di-sec.-butyl­
pyrazine (XXXVII,R=sec.-butyl). For this reason different
conditions were used for the reduction of the phenylazo- 
derivative of deoxyaspergillic acid. The phenylazo- 
derivative of deoxyaspergillic acid was reduced 
catalytically with hydrogen at ordinary pressure. There 
was obtained a small yield of product which was difficult 
to purify but was eventually obtained crystalline m.p.138- 
140°. Analysis of the product, however, could not be 
interpreted. Although the nature of this catalytic 
reduction product was not confirmed it seems probable 
that the sensitivity of the nucleus to reduction by this 
method may account for the non-isolation of the primary
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reduction product. As a satisfactory alternative method 
of converting deoxyaspergillic acid to a 2:5-diketo- 
piperazine was later adopted this line of investigation 
was not pursued.
Attempt was made to convert deoxyaspergillic acid to 
the corresponding pyrazine base. The object of this was 
to investigate the result of amination of this pyrazine 
base. Newbold (52) has shown that amination of 2:5-di­
sec .-butylpyrazine gives exclusively 5-amino-2:5-di-sec.- 
butylpyrazine which is readily characterised as its 
picrate. Assuming Dutcher*s structure of deoxyaspergillic 
acid (XXXIX), in which R^=R^=sec.-butyl, the corresponding 
pyrazine base (XXXX) would be symmetrical. Amination of 
such a pyrazine base would give a single amino-pyrazine, 
whereas, if a mixture of two pyrazine bases (XXXXI
and XXXXII) would result. As the structure proposed by 
Dutcher is the only one possible in which it was
hop „ _ »
non-identity of the alkyl groups. In attempting to 
convert deoxyaspergillic acid to the corresponding 
pyrazine base it was heated with zinc, and, in another 
experiment with zinc dust, sodium chloride and zinc
Qcxxx) (Xxxxi) fxxxxw)
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chloride mixture as recommended by Clar (67) who claims 
that enhanced yields are thus obtained in the conversion 
of hydroxy-aromatics to the corresponding aromatic 
systems. In neither case, however, was any pyrazine 
base isolated. 3-Hydroxy-2:5-dimethylpyrazine under 
similar conditions of reaction with Clar's reagent under­
went deep-seated degradation, ammonia being the only 
product of the reaction identified.
The oxidation of alkylpyrazines to pyrazine- 
carboxylic acids has been used as a preparative method 
for the latter (68). The possibility of oxidising a 
suitable derivative of aspergillic acid to the correspond­
ing pyrazine-carboxylic acid suggested itself as a means 
of confirming the location of the alkyl fragment. The 
isolation of a pyrazine-monocarboxylic acid would indicate 
that the alkyl fragment was disposed as a single alkyl 
side-chain, whereas, isolation of a pyrazine-dicarboxylic 
acid would prove that the alkyl fragment was disposed as 
two alkyl groups. As a model the oxidation of 3-chloro- 
2:5-dimethylpyrazine (XXXXIII) was examined. With 
alkaline potassium permanganate under essentially the 
conditions of Stoehr (69) for the preparation of pyrazine- 
2:5-dicarboxylic acid from 2s5rdimethylpyrazine, the 
chioropyrazine-dicarboxylic acid (XXXXIV) was not isolated.
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Failure to isolate the acid was attributed to the low
COOH COOH
Me
Me
Cl HOOC
(XXXXIII) (XXXXIV) ( x x x x v )  (XXXXVl)
yields (10-15$) general for this reaction (68). In
COOH
contrast with the low yield of pyrazine-carboxylic acids 
obtained by oxidation of alkylpyrazines, quinoxaline 
(2:3-benzpyrazine, XXXXVl) has been converted to pyrazine- 
2:3-dicarboxylic acid (XXXXV) in 80$ yield by oxidation 
with alkaline potassium permanganate (70). Concurrent 
with the model oxidation of 3-chloro-2:5-dimethylpyrazine 
the conversion of deoxyaspergillic acid to a chloro- 
pyrazine was examined. It was considered that deoxy­
aspergillic acid was unsuitable for oxidation studies as 
the presence of the hydroxyl group would increase the 
ease of oxidation of the nucleus. Conversion of deoxy­
aspergillic acid to a chloropyrazine appeared to be the 
most satisfactory method of enhancing the stability of 
the nucleus to oxidation. Prolonged treatment of 
deoxyaspergillic acid with phosphoryl chloride, however, 
failed to effect this conversion, the starting material 
being recovered unchanged.
The isolation of a pyrazine fragment by model 
oxidation of 3-chloro-2:5-dimethylpyrazine having failed, 
attention was next turned to the possibility of
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identifying the alkyl fragment of aspergillic acid by 
oxidation. By treatment of aspergillic acid or deoxy­
aspergillic acid with chromium trioxide in glacial acetic 
acid, under a variety of conditions, acetone was produced 
in very low yield and identified as its 2:4-dinitro- 
phenylhydrazone. This isolation of acetone showed that 
the group * CMe2 formed part of the alkyl fragment of 
aspergillic acid.
Summarising the information concerning the alkyl 
fragment - it consists of a Cg residue having an 
asymmetric centre. Three of the carbon atoms are 
accounted for by the group Me2C=. The probability of 
the Cq residue being a single CgH]_7 side-ehain carrying 
an asymmetric centre as well as a gem-dimethyl group 
appeared remote as did the possibility of the Cq residue 
being disposed as two alkyl groups, one of which having 
both the asymmetric centre and the = CMe2 group. These 
improbable structures being excluded the only alternative 
structures are those represented by (XXXXVII) and (IL), 
and the isomers (XXXXVIII) and (L) arising from the two 
possible positions of the hydroxyl group in the nucleus.
MeiHCHp'v. ^ w ' "xhl’v  3
if it
H C H f
( XXXXVII)  (XXXXV///) (IL) (L )
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Reactions involving the Pyrazine Nucleus.
Deoxyaspergillic acid was rapidly reduced catalytic- 
ally with hydrogen at ordinary pressure to tetrahydro- 
deoxyaspergillic acid and on treatment of the latter with 
toluene-ja-sulphonyl chloride an almost quantitative yield 
of N-toluene-p-sulphonyl-tetrahydrodeoxyaspergillic acid 
m.p* 144-146° was obtained. The structure of this 
derivative is formulated as (LI).
Monoketopiperazines as a class are but rarely mentioned 
in the literature. N-N*-Diaryl-monoketopiperazines 
(LIII) have been prepared by condensation of ethylene 
diarylamines (LII) with chloracetic acid (71) and by the 
reduction of N-N*-diaryl-2:3-diketopiperazines (LIV)(72).
N - U n s u b s t i t u t e d - m o n o k e t o p i p e r a z i n e s  h a v e  b e e n  p r e p a r e d  
a n a l o g o u s l y  b y  A s p i n a l l  (73) a c c o r d i n g  t o  t h e  r e a c t i o n
Rr (>JM)
Re
(LH) * Rr tuv)
c^xcooer -h n^ch/ h,*^
/CH, CH,/
N M  +  H X  + E J -O H
/\
R R
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giving the monoketopiperazine (LV) in which R and R^ are 
hydrogen or alkyl and X is halogen. These strongly 
basic compounds readily give crystalline toluene-£- 
sulphonyl-derivatives (73). It was hoped that on 
hydrolysis the toluene-£-sulphonyl-derivative of tetra- 
hydrodeoxyaspergillic acid would be ruptured at the cyclic 
amide link to give the open chain acid (LVI) the conversion 
of which into an N-alkyl-N-toluene-£-sulphonylamino-acid 
(LVII) according to the reaction sequence shown (p.39 ) 
appeared feasible. Synthesis of compounds of this type 
can readily be effected (74,75), treatment of the amino- 
acid (LVTII) with aryl-sulphonyl chloride giving the 
intermediate (LIX) which is alkylated to the desired 
product (LX) by treatment with alkyi halide. Hydrolysis 
of N-toluene-£-sulphonyltetrahydrodeoxyaspergillic acid 
in either acid or alkaline solution was not achieved, 
the starting material being recovered under mild conditions. 
More drastic hydrolytic conditions resulted in total 
breakdown of the molecule. The analogous oC -piperidone 
(LXI), however, is readily hydrolysed by mineral acid to 
6 -amino-n-valeric acid (LXII) (76).
(LXU)
H
(UXI)
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C-jH8 
S02 
.Nk
Hf CHR» R,
I I R-CHCHjN-CH-COOH
NHi SOljCiHb
H
(Ll) (LVl)
+ +
R^CHCHjj-N-CH-COOH J~ flgetU RiCH-CH,-N-CHCOOH OH
NMe, 5Qj . NMe3 50, 
*
RfH-CH/N-CH-COOH
SO,
C,Ha
(UVll)
R-CH-COOH *rS<w * R-CH-COOH - R-CH-COOH
NH, NH NR
50zflr 502Ar
(LVIIl) O-IX) * (L X )
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According to Dutcher (47) aspergillic acid can be 
converted into a compound which he considered to be 
identical with isoleucine anhydride. It must be emphasised 
that this compound was not analysed nor was satisfactory 
proof adduced that it was in fact a diketopiperazine apart 
from the fact that it showed physical similarity to iso- 
leucine anhydride and was not depressed in melting point on, 
admixture with it. Accordingly these experiments have been 
repeated. Aspergillic acid was converted to the compound 
^12^22^2^2 ^  "kke ^fkod °f Dutcher (47) involving 
bromination of aspergillic acid in acid solution, followed 
by zinc and acetic acid reduction of the resulting bromo- 
aspergillic acid. The compound ^ 12^ 22^ 2^2 
has I°(j|+170 as compared with [ct]o+ l 3 » Q 0 for the compound 
CigHggOgNg m.p.249-250° as described by Dutcher. This 
compound can, according to Dutcher, also be obtained by 
bromination of deoxyasiDergillie acid followed by reduction 
of the resulting bromodeoxyaspergillic acid. The 
quinone produced along with bromodeoxyaspergillic acid 
also gives this compound on reduction (p.13).
This was considered as a method of obtaining the compound 
C12H22°2N2 in racemic f°rm from racemic deoxy­
aspergillic acid. The yield, however, from bromination 
of racemic deoxyaspergillic acid did not justify con­
tinuation of this project. For comparison purposes the
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diketopiperazines, 3>L-isoleucine anhydride, DL-norleucyl- 
DL-isoleucine anhydride and DL-leucyl-DL-isoleucine 
anhydride have been synthesised. DL-isoLeucine 
anhydride (LXIV) m.p. 280-283° was prepared by two 
routes? by the method of Baxter and Spring (531 p.ZO ) 
from DL-isoleucine by heating with ethylene glycol and 
by the method of Fischer (77, for the preparation of 
leucine anhydride) from DL-isoleucine ethyl ester 
(LXIII). This last method was that used by Butcher to 
prepare DL-isoleucine anhydride although the melting 
point he quoted was 25° lower than that observed by the
€ , _ _  as that
quoted by Ehrlich (78) for an inactive isoleucine 
anhydride obtained by thermal decomposition of iso- 
leucine. DL-Norleucyl-DL-isoleucine anhydride and 
D L - l e u c y l-DL-isoleucine anhydride were prepared by 
Mr. J. J. Gallagher by the route
H
(lxiii)
H H
CHR. Q C
ftC! ■CO
HO
(LXVl) (LXV) (lxvii) ( l x v i i i ) (lxix)
H
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DL-oc -Bromo-£ -methylvaleryl bromide (LXVI^B^ssec.- 
butyl) reacted with DL-norleucine (LXV,R=n-butyl) or 
DL-leucine (LXV,R=iso-butyl) to give the N-£romacylamino- 
acid (LXVII) which after esterification (LJtVIII) was 
treated with ethanolic ammonia to give the appropriate 
diketopiperazine DL-norleucyl-DL-isoleucine anhydride 
(LXIX; R-n-butyl,R^ssec.-butyl) or DL-1eucyl-DL-iso- 
leucine anhydride (LXIX;R== iso-butyl,R^=sec.-butyl).
They were also prepared by condensation of DL-oC- 
bromo-n-hexanoyl bromide (LXVT; R^=n-butyl) or DL-oC - 
bromo-isohexanoyl bromide (LXVI; R^=iso-butyl) with DL- 
isoleucine (LXV; R=sec•-butyl) and applying the above 
series of reactions to the resulting N-oc-bromacylamino- 
acids.
It was confirmed that a mixture of the compound 
C12H22°2N2 and DL-isoleucine anhydride melted inter­
mediate between the melting points of the components.
This, however, was also true of a mixture of the compound
o
with DL-1eucyl-DL-isoleucine anhydride m.p.278 . A 
mixture of the compound with EL-norleucyl-DL-isoleucine 
anhydride m.p.258-260° showed a slight but significant 
depression of melting point. That a lack of melting 
point depression is inconclusive proof of identity of 
two diketopiperazines has been observed by Abderhaldea 
and Rossner (79) who showed that a mixture of glycyl-
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DL-norleucine anhydride m.p.219-220° and glyeyl-DL-* - 
amino-heptanoic acid anhydride m.p.221-222° was not 
depressed in melting point. The literature did not 
disclose a satisfactory method for the characterisation 
of 2:5-diketopiperazines. The melting point was not a 
suitable criterion being somewhat variable, depending 
upon the rate of heating and complicated by a tendency 
to sublimation.
In attempting to confirm the structure of the 
compound ^X2^22^2^2 as a 2:5-diketopiperazine it was 
treated with phosphoryl chloride. This reagent is 
known to bring about the aromatisation of 2:5-diketo- 
piperazines to pyrazine derivatives a reaction which is 
discussed on page5*f . By refluxing the compound 
&L2H22°2N2 with phosphoryl chloride a mixture of 
products was obtained, separable by treatment with 
aqueous sodium hydroxide into an alkali soluble fraction 
and an alkali insoluble fraction. The former, after 
crystallisation from aqueous ethanol had m.p.85-91°, 
but by recrystallisation could not be purified to 
constant melting point. It was amphoteric, dissolving 
readily in dilute mineral acid and in dilute alkali; in 
this and other physical properties it resembled closely 
deoxyaspergillic acid, with which, on admixture, it was
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not depressed in melting point. These facts suggested 
that it was probably a mixture of hydroxypyrazines 
related to deoxyaspergillic acid. The alkali insoluble 
fraction, an oil b.p. 95-100°/lmm., contained halogen 
and on vigorous treatment with potassium hydroxide gave 
a halogen-free product indistinguishable in physical 
properties from the product m.p.85-91° isolated directly. 
These results are readily explained if the compound 
^12H22^2N2 is ascril)e<i an unsymmetrical diketopiperazine 
structure (LXX), reaction with phosphoryl chloride giving 
a mixture of the two possible isomeric hydroxypyrazines 
(LXXII) and (LXXIII) in association with the correspond­
ing chloropyrazines (LXXI) and (LXXIV), the mixture of 
chloropyrazines being hydrolysed by alkaline treatment
H
oc CHR,
.CO
H
'IS-
R.
OH
(LXX)
(LXXI) (LXXII) (LXXIIl) (LXXIV)
to give the same mixture of hydroxypyrazines (LXXII)
and (LXXIII). Such a mixture of closely related 
hydroxypyrazines would be expected to prove extremely 
difficult to separate.
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Attention was next turned to the hydrolysis of 
2:5-diketopiperazines. Dutsher (47) in postulating the 
structure of the compound ^12^22^2^2 as d~M£^eucine 
anhydride considered this possibility as a means of more 
rigorous characterisation but rejected it on published 
evidence of the resistance to hydrolysis of isoleucine 
anhydride and leucine anhydride. In contrast to the 
considerable information on the hydrolysis of peptides, 
there was very little in the literature on the subject 
of hydrolysis of oC-amino-acid anhydrides, especially 
those derived from the highero(-amino-acids. The only 
reference to hydrolysis of isoleucine anhydride (78) 
states that "by prolonged heating of isoleucine anhydride 
with hydrochloric acid a product is obtained as needles 
m.p.256-257°, probably a mixture if isoleucyl-isoleucine 
dipeptides•1 Fischer (80) found that by treatment of 
leucine anhydride in a sealed tube at 100° with con­
centrated hydrobromic acid for thirty minutes leucyl- 
leucine dipeptide was produced in 66% yield, and again 
(81), that leucine anhydride is stable to alkaline 
hydrolysis, more so than alanine anhydride which with 
dilute alkali at the boiling point is hydrolysed to the 
dipeptide alanyl-alanine. L-Alanyl —L—alanine has been
hydrolysed by hydrochloric acid (82) to L-alanine. 
EL-Phenylalanine has been prepared (83) by condensation
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of benzaldehyde with glycine anhydride followed by
reduction of the 3:6-dibenzylidene-2:5-diketopiperazine
(LXXV) with hydriodic acid, the cleavage tooC-amino-acid
H
B .H O C  CO
OC. >CHPK
H (L X X V )
occurring at the same time. The hydrolysis of 2:5- 
diketopiperazines involves intermediate formation of 
dipeptides and except in the case of symmetrical diketo- 
piperazines this may give rise to two dipeptides 
depending upon which amide link is ruptured.
H
-M.
RrCH-CO NH-CH-COOH 
NH, R* iR.CH CO  ► f^-CHCONHCH-COOHNH, Ri
H
Levene and co-workers (84185,86) have examined the 
hydrolysis of 2:5-diketopiperazines and shown that the 
ease of hydrolysis decreases rapidly with increasing 
alkyl substitution in the methylene groups of glycine 
anhydride.
EE-isoLeucine anhydride was chosen for model 
experiments on the hydrolysis of 2:5-diketopiperazines. 
Dilute aqueous alkali at the boiling point did effect 
hydrolysis as evidenced by the ninhydrin reaction (p.+8 )
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but the product could not be freed from hydrolytic agent. 
Likewise hydrolysis to the amino-acid was brought about, 
under intensive conditions by hydrochloric acid, hydro- 
bromic acid and hydriodic acid, again as indicated by the 
ninhydrin reaction. Analysis of the product obtained by 
hydriodic acid hydrolysis, however, indicated that the 
hydrolysis was incomplete. The most satisfactory method 
was by refluxing DL-isoleucine anhydride with hydrobromic 
acid, DSL-isoleucine being obtained in 50# yield and 
characterised as its N-formyl-derivative by heating with 
98# formic acid (87,88).
At this stage the difficulty of identification of 
(y-amino-acids is worthy of mention. In general the 
o^-amino-acids have rather indefinite melting points, 
there is usually decomposition at the melting point, and 
the determined value is largely dependant on the rate of 
heating. Moreover, a lack of melting point depression 
with a mixture of twoo<.-amino-acids is not conclusive 
proof of identity? a mixture of DL-leucine and DL-iso­
leucine, for example, has a melting point intermediate 
between the melting points of the components. Acylation 
has been found satisfactory for identification, in 
particular N-formylation is suitable, as the N-formyl- 
derivatives of manyo(-amino-acids have been described. 
Toluene-j>-sulphonyl chloride (89) and 3:5-dinitrobenzoyl
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chloride (90) have also been recommended for this purpose.
The ninhyrdin test was used to differentiate between 
2:5-diketopiperazines, dipeptides and oC -amino-acids. 
Ninhydrin (triketohydrindene hydrate LXXVI) was introduced 
by Ruhemann (91) as a test for o<-amino-acids. That it
(LXXVI)
does not give a fi^sitive test with 2:5-diketopiperazines 
has been reported (92). This reagent has been claimed 
as giving a positive reaction with dipeptides (93) 
although other workers (94) have claimed that it is 
specific for o<-amino-acids in which both of the 
functional groups are free. Model tests showed that 
dipeptides, as represented by EL-leucyl-DL-isoleucine, 
give a colour reaction with ninhydrin which is, however, 
readily distinguished from that given by o<-amino-acids.
The compound ci2H22°2N2 on hydrolysis gave in high 
yield a product having the properties of an -amino- 
acid. The acid-free hydrolysate was subjected to 
partition chromatography on paper after the method of 
Consden, Gordon and Martin (93)* On a unidimensional 
strip with n-butanol saturated with water as the mobile 
phase, the absence of glycine, alanine, valine and 
norvaline was readily shown. The behaviour of the
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hydrolysate on the strip, however, was indistinguishable 
from that of DL-leucine, DL-isoleucine, DL-norleucine or 
a mixture of theseo(-amino-acids (p.50 ). This 
analytical method, therefore, although it did not 
establish the exact nature of the hydrolysate did confirm 
that it consisted of leucine isomers. The fact that the 
compound C^2H22^2^2 &ave leuc:i-ne isomers on hydrolysis 
established conclusively that it is a 2:5-diketopiperazine. 
The diketopiperazine is therefore represented as 
(LXXVII), and, as the optical activity of aspergillic
H
fragment, one at least, of the groups must be sec*- 
butyl. That both groups are not sec.-butyl* however, 
has previously been deduced. The isolation of acetone 
by oxidation of aspergillic acid indicates the presence 
of a=CMe2 group which on the formulation (LXXVII) for 
the diketopiperazine must arise from the other alkyl 
group, which must therefore be iso-butyl. The diketo­
piperazine ^2^22^2^2 ^ ere^ore 3-iso-butyl-6-sec.- 
butyl-2:5-diketopiperazine (LXXVIII) from which it 
follows that aspergillic acid is to be ascribed the 
structure (LXXIX) or (LXXX) and deoxyaspergillic acid
(LXXVll)H V V
acid is to be ascribed to the asymmetry of the alkyl
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Partition Chromatography of Hydrolysate on Paper 
Appearance of paper strips.
e, p, g, h,
Solvent front advanced 26 cm. (same scale)
A = Glycine B * DL-Alanine C = L-Valine
D = DL-Norvaline E = Hydrolysate F = DL-Leucine
G s= BL-isoLeucine H = DL-Norleucine
- 51 -
the structure (LXXXI) or (LXXXII).
HN
oc
>V>
H
(LXXVI It)
The fractionation of leucine isomers has been 
reported. Ehrlich (95) was able to separate L-leucine 
and L-isoleucine; a method based on the difference in 
solubility of their copper salts, and the method has 
been extended to the separation of the more complex 
mixture of of -amino-acids resulting from hydrolysis of 
the protein zein (96). An infra-red analysis of 
leucine and isoleucine mixtures has been evolved (97) 
using bands, given by the acetyl derivatives of these 
o(-amino>-acids in the 700 cm~^ region.
The hydrolysate was converted to its copper salt 
which was separated into a relatively water soluble
fraction and a relatively water insoluble fraction.
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These fractions were then individually reconverted to 
the parent oC-amino-acid by treatment with hydrogen 
sulphide. Theoretical consideration of the nature of 
the hydrolysate will explain the subsequent procedure 
adopted for the confirmation of the nature of these two 
amino-acid fractions.
The diketopiperazine 2^22^2^  has "three asymmetric 
centres, two of which were introduced in its formation 
from aspergillic acid; it will therefore be racemic 
with respect to these two centres by virtue of their 
mode of formation. Hydrolysis of the diketopiperazine 
will therefore give rise to DL-leucine and oC-amino-£ - 
methylvaleric acid racemic with respect to the ot-carbon. 
There are four possible isomers of oC-amino-ft -methyl- 
valeric acid represented conventionally by (LXXXIII) to 
(LXXXVI), of which structures one optical pair represents
HH H
Me-
HfT
•& El-
•COOH HOOC-
H
Me Me*
■NH* HOOC-
-tt ET-
NKi
■Me
•COOH
HH n H
(LXXXIll) (lxxxiv) (l x x x v ) (l x x x v i)
DL-isoleucine and the other DL-alloisoleucine. The
<^-amino-p -methylvaleric acid component of the hydrolysate
will consist of a non-optical pair (active isoleucine and
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active alloisoleucine of the same(5 -configuration), or 
less likely, if^ -racemisation has occurred, will 
consist of all four possible isomers (DL-isoleucine 
and DL-alloisoleucine). Theoretically the hydrolysate
consists of 50% EL-leucine, 25% isoleucine and 25% 
alloisoleucine. If£ -racemisation has not occured 
the [pGo ot such a mixture can be estimated using the 
physical constants of isoleucine and alloisoleucine 
reported by Abderhalden and Zeisset (98) and given in 
tabular form.
Amino-acid U\o Amino-acid l°ch
L(-Oisol>eucine +10*7° D(-)alloisoLeucine -14*2°
D(-)isoLeucine -10-7° L(-OalloisoLeucine +14-2°
L-isoLeucine has the same 0 -configuration as D-alloiso-
leucine
M 0Hydrolysate=-25x fcC“L isoleucine +.25x {k]0 alloisoleucine
14*2 - 10*7 
4
=± 0-88°
As this computed value is so low, the fact that the 
observed [otj0of the hydrolysate =0*1° cannot be taken as 
evidence that § -racemisation of theot-amino-ji -methyl- 
valeric acid has taken place during hydrolysis of the 
diketopiperazine ^i2H22^2^2*
To avoid separating isoleucine and alloisoleucine
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a method was sought of identifying the one in presence 
the other. This was most readily attainable by removal 
of one of the centres of asymmetry. The Strecker 
degradation presents a ready method of removing the 
asymmetry about this ok-carbon atom. In this reaction 
o< -amino-acids are degraded to the corresponding 
aldehydes or ketones containing one carbon atom less, 
by the action of certain carbonyl compounds. Strecker 
(99) observed that alloxan (LXXXVII) reacted with 
alanine with the formation of acetaldehyde.
HN CO
I +  CH5 CHC00H  *  CH^CHO
io
’U (lxxxvi i)
It has been shown (94) that the reaction is general 
for carbonyl compounds having the grouping CO-(CH=CH)n-CO 
where n=0 or any integer, and is specific foroC -amino- 
acids in which the amino group is unsubstituted. The 
mechanism of the Strecker degradation has been 
postulated (94) as
- C * 0  -C=N-CHRCOOH - C - N C H ^ R  - C - N ^ C H R  —C~ NH,
| _  I ^  | |  | +RCHQ
—o = 0  - C - 0  - C - O H  - c ^ o
In effecting Strecker degradation ninhydrin has been 
extensively used (94), it having been shown that both 
leucine (100,101) and isoleucine (101) undergo reaction 
with this reagent, although in neither case was the
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resulting aldehyde characterised.
The amino-acid regenerated from the more water 
soluble copper salt (p.5/ )< when reacted with ninhydrin
in an inert atmosphere gave methyl ethyl acetaldehyde, 
characterised as its 2:4-dinitrophenylhydrazone, 
identical (melting point and mixed melting point) with 
that obtained by similar degradation of authentic DL- 
isoleucine. The observed melting point of methyl 
ethyl acetaldehyde 2:4-dinitrophenylhydrazone, 130°, 
was 9° higher than that recorded by Morgan and Hardy 
(102). Confirmatory evidence was deduced by a total 
synthesis of methyl ethyl acetaldehyde after Linstead 
and Mann (103) by the route
^ > H 8 r  * > H C H (0 Eh), ^  ^ C H C H O
the 2:4-dinitrophenylftydrazone of this synthetic 
product being identical with that of the aldehyde 
obtained from DL-isoleucine.
The other component of the hydrolysate was con­
firmed as DL-leucine by two methods. It was converted 
to its N-3:5-dinitrobenzoyl-derivative (90) which was 
undepressed in melting point with N-3:5-dinitrobenzoyl- 
DL-leucine and depressed in melting point with either 
N-3:5-dinitrobenzoyl-DL-isoleucine or N-3:5-dinitro- 
benzoyl-DL-norleucine. Secondly it was subjected to 
Strecker degradation and the isovaleraldehyde produced
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characterised as its 2:4-dinitrophenylhydrazone, which 
was identical with a specimen prepared from authentic 
DL-leucine.
Flavacol and 3-Hydroxy-2:5-di-iso-butylpyrazine.
As described on p.83 flavacol was separated from 
aspergillic acid, in association with which it is 
produced by growth of A. flavus on a tryptone or 
"Pronutrin" medium containing sodium chloride. In 
physical properties it resembles deoxyaspergillic acid 
with which it is isomeric. The similarity in ultra­
violet absorption spectra between flavacol and deoxy­
aspergillic acid was so marked as to suggest a very 
close relationship between the two. Deoxyaspergillic 
acid having been shown to have the structure (LXXXVIII) 
or (LXXXIX), the possibility of flavacol having the 
alternative structure (LXXXIX) or (LXXXVIII) was con­
sidered. Qther structures which appeared worthy of 
consideration were the other isomeric 2:5-dialkylhydroxy- 
pyrazines in which the alkyl groups were iso-butyl or 
sec.-butyl. This latter consideration offered two 
further possibilities, 3-hydroxy-2:5-di-sec«-butylpyrazine 
(XC) and ^-hvdroxy-2:5-di^iso-butylpyrazine (XCI).
£HC
(lxxxvw )
M
(LXXXIX)
a/
(XC)
'\ef 
OH
t*HCHf
CH,CH(£
(XCI)
OH
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Flavacol differed from 3-hydroxy-2:5-di-sec.-butyl" 
pyrazine (XC). As synthetic routes to compounds 
(LXXXVIII) and (LXXXIX) are not known (see p.6* for 
consideration of these syntheses) the possibility of 
synthesis of (XCI) for comparison was examined.
The synthesis of 3-hydroxy-2:5-di-iso-butylpyrazine 
(XCIII) followed the general method of Baxter and Spring 
(53> p. 20 ) for the synthesis of 3-hydroxy-2:5-di-sec.- 
butylpyrazine. DL-Leucine anhydride (XCII) prepared 
after Sannie (104) by heating DL-leucine with ethylene 
glycol, on treatment with phosphoryl chloride gave
d i r e .............. -------------------------- ^ _____
Although Baxter and Spring (53) did not isolate directly 
the hydroxypyrazine, but obtained it by hydrolysis of 
the chloropyrazine produced, direct dehydration of 
2:5-diketopiperazines has previously been observed. 
DL-Phenylglycine anhydride on treatment with phosphoryl 
chloride gives 3-hydroxy-2:5-diphenylpyrazine (105) and 
similar treatment of DL-leucyl-DL-isoleucine anhydride 
gives a hydroxy-2-iso-butyl-5-sec.-butylpyrazine.
Treatment of DL-leucine anhydride with phosphoryl
H
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chloride gave in addition to 3-hydroxy-2:5-di-iso- 
butylpyrazine , a mixture of chloropyrazine derivatives 
which could not be separated directly. Analysis 
indicated that the mixture probably consisted of 
3-chloro-2;5-di-iso-butylpyrazine (ICIV) and 3:6- 
dichloro-2:5-di-iso-butylpyrazine (XCV).
The presence of the former was confirmed by treatment 
of the mixture with sodium ethoxide followed by acid 
hydrolysis of the product, 3-hydroxy-2;5-di-iso-butyl- 
pyrazine being isolated.
Flavacol (p.25 ) was identified as 3-hydroxy-2:5- 
di-iso-butylpyrazine. They have identical physical
properties, show the same light absorption in the 
ultra-violet (Fig* I) and a mixture of the two was not 
depressed in melting point.
It has been shown that aspergillic acid can be 
degraded to a mixture of leucine isomers, and, based on 
the identification of these isomers, the alternative 
formulae of aspergillic acid were established. Such a 
mixture of leucine isomers would likewise be produced 
if aspergillic acid were a mixture of i-hydroxy-2-keto-
(xciv) (XCV)
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3:6-di-iso-butyl-l:2-dihydropyrazine (XCVI) and 1-hydroxy-
2-keto-3-6-di-£ec.-butyl-l:2-dihydropyrazine (XCVII). 
Establishment of the structure of flavacol showing as it 
does that A. flavus is able to synthesise 3-hydroxy-2:5- 
di-iso-butylpyrazine, which has the C-N skeleton of (XCVI),
made this a more serious consideration. It was, therefore, 
necessary to disprove the possibility of aspergillic acid 
being a mixed crystal formation of the two pyrazine 
cyclic hydroxamic acids (XCVI) and (XCVII) and deoxy­
aspergillic acid a mixed crystal formation of the corres­
ponding hydroxypyrazines. As 3-hydroxy-2:5-di-iso-butyl­
pyrazine and 3-hydroxy-2:5-di-sec.-butylpyrazine were 
available the method adopted was to examine mixtures of 
these two hydroxypyrazines for evidence of formation of 
mixed crystals identical with deoxyaspergillic acid. A 
mixture of 50# 3-hydroxy-2:5-di-iso-butylpyrazine and 50# 
3-hydroxy-2:5-di-sec.-butylpyrazine was examined.
Fractional crystallisation of such a synthetic mixture 
failed to show any evidence of a sharp-melting entity, 
all crops melting over a wide range.
J=0
K
OH (XCVI) OH (XCVII)
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Biogenetic Considerations.
Elucidation of the structure of aspergillic acid 
stimulates interest in the biosynthesis of the antibiotic, 
the structure being novel amongst natural products. 
Produced as it is by growth of the organism on a protein 
hydrolysate medium, the utilisation of oi-amino-acids 
immediately suggests itself. The amino-acid precursors 
of such a structure, leucine and isoleucine are known to 
be present in casein hydrolysate (106). Attempt was 
therefore made to produce aspergillic acid on a synthetic 
medium consisting of these amino-acids. It was known 
that aspergillic acid is produced on a medium of enzymic 
digest of casein but not on acid digested casein, a fact 
that was attributed to the destruction of tryptophane 
during acid hydrolysis of the protein. For this reason 
tryptophane was added to the synthetic medium of leucine 
and isoleucine. On this medium,, however, not only was 
aspergillic acid not produced, but, in addition, there 
was negligible growth of the organism. Failure of A. 
flavus to grow on this synthetic medium is most probably 
to be attributed to vitamin defficiency rather than 
unsuitability of the primary components.
The conversion of leucine and isoleucine to 
aspergillic acid involves a dehydration and an oxidation
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reaction expressed empirically.
The isolation of flavacol may have some bearing on this 
reaction, showing as it does that A. flavus is able to 
synthesise a hydroxypyrazine. This suggests that 
deoxyaspergillic acid may be the precursor of aspergillic 
acid, that is, that the oxidation reaction occurs after 
cyclisation. That an isomer of aspergillic acid, 
l-hydroxy-2-keto-3:6-di-iso-butyl-l:2-dihydropyrazine 
(XCVIII) is not also produced from flavacol must be 
attributed to the specificity of the oxidation reaction,
Although biogenetic formation of deoxyaspergillic 
acid seems probable, the prior mode of cyclisation is 
doubtful. The obvious mechanism, through intermediate 
formation of the diketopiperazine leucyl-isoleucine 
anhydride is improbable, as conclusive evidence of the 
biosynthesis of 2:5-diketopiperazines is rare. At one 
time considered to form part of many protein molecules, 
it has since been accepted that the isolation of
OH
(XCVIIt)
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2:5-diketopiperazines from protein hydrolysates results 
from secondary condensation of oL-amino-acid residues (107). 
It has, further, been shown that 2:5-diketopiperazines 
cannot be metabolised by animals (108) or micro-organisms
Abderhalden has shown thatoc-amino-acid anhydrides 
can exist in two distinct isomeric forms, the true diketo­
piperazine (XCIX) and the enol-acid anhydride (C) (110). 
The 2:5-diketopiperazine can, by physical means (111), 
be converted to the enol form which shows greatly enhanced
H M
resistant to enzymic attack. This enol-acid anhydride 
(C;Rj^iso-butyl,Rp-sec.-butyl) therefore may be the 
primary cyclic product in the biosynthesis of aspergillic 
acid, its structure as a dihydropyrazine suggesting that 
it would readily be converted, by loss of water, to the 
hydroxypyrazine deoxyaspergillic acid.
(109)
n (xcix) [T
chemical reactivity (112) and, unlike the f<ormer is not
SECTION II.
This section is devoted to model experiments the 
object of which was to investigate synthetic routes to 
racemic deoxyaspergillic acid and racemic aspergillic 
acid. Considering firstly the synthesis of racemic 
deoxyaspergillic acid which has either the structure 
(Cl) or (CII) the problem was one of developing a
synthesis of 3-hydroxy-2:5-dialkylpyrazines in which 
the two alkyl groups are dissimilar. Having developed 
such a synthesis it would be expected that its 
application to appropriate starting materials would 
give either of the above structural forms. The methods 
available for the synthesis of 3~hydroxy-2j5~dialkyl- 
pyrasines will therefore be examined and their possible 
application to the synthesis of the general form (CIII) 
considered.
(cm)
By treatment of the bisulphite compound of 
isonitroso-acetone with potassium cyanide followed by
2:5-dimethylpyrazine (CIV, R ^ R ^ M e )  which on alkaline
(Cl) (CII)
hydrochloric acid, Gastaldi (113) obtained 3:6-dieyano-
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NC HOOC
hydrolysis gave the hydroxyacid (CV) the latter on 
decarboxylation giving 3-hydroxy-2:5-dimethylpyrazine 
(CVI, R^=R2=Me). The same series of reactions applied 
to the bisulphite compound of isonitroso-acetophenone
(CIV) (CV) (cvi)
gave 3-hydroxy-2:5-diphenylpyrazine (CVI,R^=R2=Ph).
The Gastaldi synthesis applied to the bisulphite compound 
of isonitroso methyl ethyl ketone (114) gave 3-hydroxy- 
2:5-diethylpyrazine (CVI,R^=R2=Et) .• Golombok and Spring
(115) attempted to extend the Gastaldi synthesis to the 
preparation of 3-hydroxy-2:5-dialkylpyrazines in which 
the alkyl groups were dissimilar. By reaction of 
potassium cyanide with a mixture of the bisulphite 
compounds of isonitroso-acetone and isonitroso-aceto­
phenone with the bisulphite compound of a mixture of 
isonitroso-acetone and isonitroso-acetophenone they were 
unable to isolate any 3:6-dicyano-2-methyl-5-phenyl- 
pyrazine (CIV; R^=Me, Rg=Ph) but obtained only 3:6- 
dicyano-2:5-dimethylpyrazine (CIV, R1=R2=Me) and 3:6- 
dicyano-2:5-diphenylpyrazine (CIV, R1=R2=Ph).
By treatment of the <*-bromacyl-derivative of an 
-amino-ketone (CIX) with ammonia Tota and Elderfield
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(116) obtained hydroxypyrazines. By this method 
6-hydroxy-2:3-dialkylpyrazines (CX,R^=H) and 2-hydroxy- 
3:4:5-trialkylpyrazines (CX) were obtained.
A modification of this method was adopted by 
Newbold, Spring and Sweeny (117) in which anoC-amino- 
methyl ketone (CVII, I^H) was used in attempting to 
prepare 2-hydroxy-3:5-dialkylpyrazines (CX, R2=H), but 
instead they obtained 3-acylamino-2:5-dialkylpyrazines 
which were readily converted to 3-hydroxy-2:5-dialkyl- 
pyrazines. ot-Brompropionyl bromide (CVTII, R^=Me) 
reacted with aminomethyl ethyl ketone (CVII; Rj=Et,
R2=H) to give (CXI,R=Et), two molecules of which reacted 
with one molecule of ammonia to give (CXII, R=Et). The 
last mentioned was readily hydrolysed to the amino- 
pyrazine (CXIII, R=Et) which on treatment with nitrous 
acid gave 3-bydroxy-2:5-diethylpyrazine (CXIV,R=Et).
The same reaction was used to prepare 3-hydroxy-2:5- 
dimethylpyrazine (CXIV,R?=Me) and 3-hydroxy-2:5-diphenyl- 
pyrazine (CXIV,Rs=ph). Extension of this reaction to 
the preparation of racemic deoxyaspergillic acid would
H
(CVII) (CVIH) (CIX) (CX)
67
R'CO CH^'NH-COCHBrnc
OCR
TfH
R (] ^NHC0CH2CHb
\ N
9° (ext) (exit)
MeCHBr
t
hOH Rrf/ f X NHa
X ^ R
" (CXIIl)
involve cyclisation of a mixture of two o(-bromacyl amino - 
ketones and would at best be expected to give the 
desired product in association with a mixture of the 
two symmetrically substituted 3-hydroxy-2:5-dialkyl- 
pyrazines.
Another modification of the method of Tota and 
Elderfield, in which an o(-amino-aldehyde was substituted 
for an c(-amino-ketone has been developed (118) as a 
synthetic route to 3-hydroxy-2:5-dialkylpyrazines, the 
carbonyl group being protected as a thioacetal group 
until the final stage of the reaction. The diethyl 
acetal of o(-amino-propionaldehyde (CXY,R=Me) condensed 
with o<-brompropionyl bromide (CXVIjR^Me) to give the 
intermediate (CXVII) treatment of which with mercuric 
chloride and cadmium carbonate resulted in the liberation 
of the free aldehyde which cyclised with ammonia to give
3-hydroxy-2:5-dimethylpyrazine (CXVIII, R=R^=Me). This
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route could obviously be used for the unambiguous 
Be Br
CH(Stl)j CHR, CH(i£»V X CHR, R.
OH
R &  i o  rIh co rs\ nX ’
(CXV)^NH*  B f ( t X V l )  ' J j  (CXVII) (CXVUl)
synthesis of racemic deoxyaspergillic acid and is at 
present being investigated by Mr. Sweeny.
Baxter and Spring (53»p« H ) prepared 3-hydroxy- 
2:5-dialkylpyrazines, in which both alkyl groups were 
the same, by the reaction of phosphoryl chloride with 
o(-amino-acid anhydrides and hydrolysis of the resulting 
chloropyrazines. Mr. J. J. Gallagher has investigated 
the application of this reaction to mixed o( -amino-acid 
anhydrides. Treatment of DL-leucyl-DL-isoleucine 
anhydride (p. *1 ) with phosphoryl chloride gave a 
hydroxy-2-iso-butyl-3-sec.-butylpyrazine of m.p.97°) 
which differed from racemic deoxyaspergillic acid. This is 
an ambiguous synthesis the location of the hydroxyl 
group at the 3-or-6-position being indeterminate.
The synthesis of racemic 3-hydroxy-2:3-di-sec. - 
butylpyrazine by Newbold and Spring (48) was outlined 
(p. IS ). Extension of this sjfathesis to give mixed 
dialkyl-hydroxypyrazines would involve the condensation 
of different amino-ketones and would not be unidirectional.
Mr. Ramsay investigating pyrazine cyclic hydroxamic 
acids has developed a synthesis of l-hydroxy-2-keto-
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3:6-disubstituted-l:2-dihydropyrazines in which the 
substituents need not be similar. Condensation of 
of-bromeinnamaldehyde with glycine-hydroxamic acid 
(CXIX,R=H) gave the Schiff base (CXX,R=H) which cyclised 
and aromatised on treatment with sodium ethoxide to give
l-hydroxy-2-keto-6-benzyl-l:2-dihydropyrazine (CXXI,R=H). 
The same series of reactions starting from o(-amino-n- 
butyro-hydroxamic acid (CXIX,ft=Bt) gave l-hydroxy-2- 
keto-3-ethyl-6-benzyl-l:2-dihydropyrazine (CXXI, R=Bt).
This synthesis lending itself, as it does, to the 
synthesis of cyclic hydroxamic acids related to aspergillic 
acid, suggested analogous syntheses of compounds related 
to deoxyaspergillic acid by use of cC-amino-acid amides 
in lieu ofo(-amino-hydroxamic acids.
Initial investigation was carried out on the reaction 
between glycine amide and oc-bromcinnamaldehyde. The 
former was prepared by the method of Yang and Rising 
(119) from glycine ester prepared by Fischer*s method 
(77). c*-Bromcinnamaldehyde was readily prepared from 
cinnamaldehyde by the method of Zincke and Hagen (120). 
Reaction of this aldehyde with glycine amide in boiling
»CHPhCO
>SsNM
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ethanol was associated with considerable darkening in 
colour, in contradistinction to the clean interaction of 
this aldehyde with glycine-hydroxamic acid (121), and 
the Schiff base could not be isolated from the resulting 
tar. Allowing the reaction to proceed at lower 
temperature did not overcome this tar formation. As the 
Schiff base could not be isolated the reaction product 
was treated directly with sodium ethoxide and worked up 
for hydroxypyrazine but none was isolated, nor was any 
identifiable product obtained. Attention was next 
turned to the use of substituted glycine amide as it was 
realised that unsubstituted methylene groups, in the 
potential pyrazine ring, frequently cause anomalous 
reaction (p.75 ). DL-Alanine amide prepared from Dl- 
alanine ester (77) was therefore selected and subjected 
to the same series of reactions as glycine amide but with 
the same lack of success. In a similar manner DL-alanine 
ester and o(-bromcinnamaldehyde gave an intractable 
reaction mixture which was heated with ammonia in view 
of the possibility of effecting the synthesis by the 
alternative route indicated. The reaction mixture, 
however, gave no hydroxy-pyrazine. As distinct from the
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reaction withc*-bromcinnamaldehyde, DL-alanine amide 
reacted smoothly with cinnamaldehyde to give cinnamylidene- 
DL-alanine amide m.p.154-155°• This Schiff base was
readily hydrolysed by dilute mineral acid; on standing 
with Brady's reagent the 2:4-dinitrophenylhydrazone of 
cinnamaldehyde separated almost at once.
This disparity in results between condensation of 
oC-bromcinnamaldehyde with o(-amino-acid amides on the 
one hand and o( -amino-hydroxamic acids on the other was 
attributed to the acidity of the latter. It was 
therefore considered desirable to investigate the reaction 
between o( -bromcinnamaldehyde and o(. -aminoacyl-sulphonamides 
in the hope that the acidity due to the sulphonyl group 
would enforce the condensation, and at a later stage be 
removable by hydrolysis according to the scheme
(cxx..)*°*Rr
N-(o<-Brompropionyl)-toluene-£-sulphonamide was prepared 
by a modification of the method of Openshaw and Spring 
(122) for the preparation of sulphonacetamides, 
o(-brompropionyl bromide condensing with toluene-£- 
sulphonamide to give in 73% yield the bromacylsulphonamide,
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treatment of which with aqueous or ethanolic ammonia at 
room temperature gave N-(DL-alanyl)-toluene-p-sulphonamide 
(CXXII; Ar=£-tolyl,R=Me) m.p.234-235° (decomp.) in almost 
quantitative yield. With liquid ammonia in a sealed 
tube at slightly elevated temperature ammonolytic fission 
occurred and toluene-p-sulphonamide was regenerated. 
N-(DL-Alanyl)-toluene-£-sulphonamide after prolonged 
refluxing with <X-bromcinnamaldehyde in ethanol was recovered 
unchanged. More drastic conditions caused the formation 
of an intractable tar.
Concurrent with these experiments, possible synthetic 
routes to compounds related to aspergillic acid were 
examined. There were two general approaches to this 
problem; firstly to obtain the cyclic hydroxamic acid by 
oxidation of preformed pyrazine derivatives and secondly 
to evolve a synthesis in which the final ring closure 
involves simultaneous formation of the pyrazine ring and 
the hydroxamic acid grouping. The former approach has 
been examined (123). 2-Ethoxypyridine (CXXIII) and 2- 
ethoxyquinoline being peroxidised to the corresponding 
N-oxides, acid hydrolysis of which gave the pyridine 
(CXXIV) and quinoline cyclic hydroxamic acids. Application 
of this method to2-ethoxypyrazine (124) and 2-ethoxy- 
quinoxaline (125) results however in oxidation of the
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nitrogen atom remote from the ethoxy group. The 
peroxidation of 3-ethoxy-6-cyano-2:5-dimethylpyrazine 
has been examined (115) to find if the cyano group would
atom adjacent to the ethoxy group. The cyano-compound 
did give an N-oxide but subsequent hydrolysis caused 
total rupture of the molecule.
On the other approach to the synthesis of pyrazine 
cyclic hydroxamic acids, viz. by simultaneous formation 
of the pyrazine ring and the hydroxamic acid grouping 
there was no information in the literature. The 
synthesis of certain pyrazine cyclic hydroxamic acids by 
Mr. Ramsay has been outlined (p.68 ) and is being 
developed with the object of synthesis of aspergillic 
acid.
A further synthesis of pyrazine cyclic hydroxamic 
acids based on simultaneous formation of the pyrazine 
ring and the hydroxamic acid grouping has been developed 
in collaboration with Dr. Newbold and Mr. Sweeny. This 
synthesis consists of reacting ot-amino-hydroxamic acids
enforce 4-oxidation, that is, oxidation of the nitrogen
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with-dicarbonyl compounds, a development of the method 
of Jones (126) for the preparation of 2-hydroxy-3:5- 
disubstituted and 2-hydroxy-3:5:6-trisubstituted-pyrazines, 
from o(-amino-acid amides ando(-dicarbonyl compounds. 
Treatment of glycine-hydroxamic acid (CXXVjt^H) prepared 
after Jones and Sneed (127) with phenyl glyoxal (CXXVI; 
R2=Ph,Ry=H) under essentially the conditions of Jones 
(loc.cit.) gave in very low yield 1-hydroxy-2-keto-5- 
phenyl-1:2-dihydropyrazine (CXXVII;R1=R^=H,R2=Ph) 
m.p.194-196°(decomp.). With either methyl glyoxal
NHs
K,CH
v
(cxxv)
ft
* v
HH
I
OH
S'
OH (W X V ")
R*
(CXXVIH)(cxxvi) °d
(CXXVI;Rg^Me,Ry=H) or diacetyl (CXXVI,R2^ = M e ) and 
glycine-hydroxamic acid (CXXV,R^=H) there was indication 
of cyclic hydroxamic acid formation. In small yield in 
each case, a product was obtained which sublimed in high 
vacuum and gave the colour reaction of hydroxamic acids 
with ferric chloride reagent. In neither case however 
was sufficient material obtained for analysis.
Dr. Newbold and Mr. Sweeny have prepared a number of 
3:5-disubstituted (CXXVII,Ry=H) and 3:5:6-trisubstituted-
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1-hydroxy-2-keto-1 :2-dihydropyrazines (CXXVII) using the 
appropriate starting materials. In all the cases they 
examined using ^-keto-aldehydes (CXXVI,R3=H) as the 
dicarbonyl compound they have shown that of the two 
possible products (CXXVII,R3=H) and (CXXVIII,R3=H) the 
unsymmetrieal isomer is formed to the exclusion of the 
other. The structure of 1-hydroxy-2-keto-5-phenyl-1:2- 
dihydropyrazine could not be rigorously established but 
was implied from these results. In the condensations 
examined by the author between glycine-hydroxamic acid 
and <*-dicarbonyl compounds, the yields were extremely 
low in comparison with the favourable yields observed 
by Dr. Newbold and Mr. Sweeny, using homologues of 
glycine-hydroxamic acid (CXXV, Ri=Me or Ph). Anomalous 
results have previously been observed where the first 
member of the series has been subjected to typical 
reactions. Thus glycine anhydride or pyrazine-N-oxide 
on treatment with phosphoryl chloride does not give the 
anticipated chioropyrazine derivatives (127).
EX? ER IREN T AL
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EXPERIMENTAL 
All melting points are uncorrected.
SECTION I.
Aspergillic Acid.
(Adapted from White and Hill, J.Baet.,1943,45,433)
(a) The culture medium consisted of 2% "Pronutrin"
(a commercial enzymic digest of casein prepared by Herts 
Pharmaceuticals Ltd.) and 2% sodium chloride dissolved 
in distilled water. Sterilisation was by steam auto- 
claving (15 lbs., 15 minutes), the resulting solution 
being pale yellow in colour and containing a small quantity 
of grey sediment. After autoclaving the solution was 
slightly acid (^H 5*4-5*6). The inoculum was prepared 
from beer wort agar slopes of Aspergillus flavus which 
had been incubated 10 days at 25°. Spores from two sudh 
slopes were added to sterile distilled water (100ml.) and 
shaken to give a uniform spore suspension. The medium 
was dispensed (350ml.) in standard penicillin flasks, 
giving a layer 1*5 cm. deep, and after sterilisation was 
inoculated with the standard inoculum (5ml.). The flasks 
were incubated at 23 + 1° for 14 days (optimum time for 
maximal antibacterial titre; Gowenlock, private communi­
cation). Growth was scanty, isolated colonies appearing 
after 48 hours and after 7 days the surface was covered
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by a thin white mycelial membrane. About the twelfth
day there was slight sporulation. During incubation
there developed a bright orange pigment, which settled to 
the bottom of the flask. In a typical batch of 100 
flasks the mycelial matter was removed and the bulked 
culture filtrate (331.; pH ,7 *8) was adjusted to pH 4 by 
addition of dilute hydrochloric acid. Acidification 
precipitated much of the suspended matter as a reddish- 
brown sludge; this was filtered and the filtrate stirred
with charcoal (660g.) for 3 hours. The charcoal was
filtered, air-dried and ether extracted (Soxhlet) until 
the initially red percolate was colourless. The bright 
red ethereal solution was concentrated to about 250ml. 
and shaken with 2N-sodium hydroxide (150ml.). The brown 
amorphous solid which separated from the mixture was 
filtered and the layers separated. The ether layer was
re-extracted with 2N-sodium hydroxide (150ml.) and the 
alkaline extracts bulked. The yellow alkaline solution 
was acidified with 33# aqueous acetic acid and chilled 
overnight. The solidified gum which had separated was 
filtered and shaken with 2# sodium hydrogen carbonate 
solution (400ml.) for 6 hours and filtered from gummy 
residue (solid A). The chilled sodium hydrogen carbonate 
solution was acidified to pR4 by dropwise addition of
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3N-hydrochloric acid, with stirring, over several hours.
The precipitated aspergillic acid was filtered and dried
over phosphoric oxide to a free-running microcrystalline
yellow powder m.p.80-85° (8g., 250mg./l of culture
filtrate). Crude aspergillic acid was purified by re-
dissolving in aqueous sodium hydrogen carbonate and
precipitating with dilute hydrochloric acid at pu4,
n
followed by sublimation at 80°/0*001mm. and repeated 
crystallisation from methanol. This gave aspergillic 
acid m.p.97-99° as radial clusters of yellow needles.
Found: 0=64*2,64*5; H=8.90,8*91; N=12*3%
Calc, for C12H20°2N2: c=64#5» H=8*93, N=12*5#
M o  +13*3° (l,l,c,3*9, in ethanol)
o
Light absorption in ethanol: Maxima at 2340A, £ =10,500;
o
3280A,£ =8500. 
pka =5 *95.
(b) The conditions were the same as previously 
described except that the culture medium contained 2% 
"Difco" tryptone instead of 2% "Pronutrin". The cultural 
characteristics differed in that less pigment was produced. 
The culture filtrate on being worked up in the usual 
manner gave similar yields of aspergillic acid. The 
purified product m.p.96—98° was undepressed in melting 
point with a specimen described above.
Isolation of Flavacol.
The sodium hydrogen carbonate insoluble gum (solid 
A from preparation of aspergillic acid) was shaken with 
2N-sodium hydroxide (20ml.) for 1 hour and filtered from 
gummy residue. The solution was neutralised (litmus) 
with dilute hydrochloric acid and extracted with ether 
(3 x 15 ml.). The combined ether extract was shaken with 
3N-hydrochloric acid (3 x 10 ml.) and the acidic extract
neutralised (litmus) with dilute sodium hydroxide. The
\
precipitate which separated was filtered and sublimed in 
high vacuum (80°/0*005mm.). After two crystallisations 
from aqueous ethanol the product separated as needles 
m.p.120-130°(50mg.). On repeated crystallisation from 
aqueous ethanol pure flavacol was obtained as long needles 
mp.144-146°.
Analysis of specimens from different batches.
Founds C=68*9>68.9,69*0; H=9*35,9-55,9*54; N=13*7% 
C12H200N2
requires; C=69*2, t H=9*62, N=13*5%
o
Light absorption in ethanol: Maxima at 2280A, £ =7300;
o
3260A, £ =7900.
Flavacol was insoluble in cold water and aqueous sodium 
hydrogen carbonate. It dissolved readily in ether, 
methanol, ethanol, 3N-hydrochloric acid and 3N-sodium
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hydroxide in the cold. It did not give a colouration 
with ferric chloride solution. The compound sublimed 
readily at 10Q°/0#001mm.
Growth of A. flavus on a Culture Medium containing Brown 
Sugar.
The culture medium consisted of 2% "Pronutrin", 2# 
brown sugar (Demerara type) and 0*5% sodium chloride 
dissolved in distilled water. Sterilisation, volume of 
medium per flask and inoculum were as in the production 
of aspergillic acid. The sterilised medium was slightly 
acid (pH 6*2). The flasks were incubated at 23+1° for 
seven days (optimum time for maximal antibacterial titre; 
Gowenlock, private communication). There was prolific 
growth such that, after 48-72 hours the entire surface 
was covered by a thick white mycelial mat, and after five 
days the surface was covered with golden spores. The 
culture filtrate (pH7*5) was worked up as described for 
aspergillic acid. The product could not be purified to 
constant melting point, continued crystallisation caused 
progressive rise in melting point.
Analysis of a sample of this material m.p. 106-110°, W d  
+13.7° (l,l,c,3-8, in ethanol)
Found: C=63*4, H=8*58#
Calc, for ^2.2^20^2^2* H=8.935&
Calc, for ^12^20^3^22 0=60*0, H=8*33$
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After repeated crystallisation from methanol the 
product had m.p.130-132°.
Dried for analysis this specimen had m.p.135-137°.
Found: C=61»8, H=8«5%
Calc, for C12H2002N2: C=64-3, H=8.9#
Calc, for C12H2003N2: C=60«0, H=8.3#
Hydroxyaspergillic acid has m.p.149° (Menzel, Wintersteiner 
and Rake, J.Bact., 1943, 46, 109).
Kojic Acid.
Kojic acid was isolated from one hatch of A. flavus 
grown on a medium of 2% "Pronutrin1*, 2% brown sugar and 
0*5$ sodium chloride. Cultural conditions were as 
previously described for growth of A. flavus on this 
medium. The culture filtrate (5 1.) was adjusted to 
pR4 with dilute hydrochloric acid, stirred with charcoal 
(lOOg.) for several hours, and the charcoal air-dried.
The charcoal was ether extracted (Soxhlet) and the ether 
extract concentrated to 150ml. The ether insoluble solid 
was filtered (2*lg., 40Gmg./l. of culture filtrate) and, 
crystallised from methanol, separated as brown coloured 
blades m.p.150-152° (880mg.), 2nd Crop m.p.l48-151°(750mg.). 
After sublimation at 130 /O*0001mm. and crystallisation 
of the sublimate from ethanol, kojic acid separated as 
blades m.p.151-153°• The melting point was not raised
- 82 -
by further crystallisation.
Found: 0=50-8, 50-9; H=4-30, 4-55#
Calc, for CgHgO^: 0=50-7, H=4*23%
Equivalent Weight*by titration with barium hydroxide 
(phenolphthalein) 164,166. Theory 142.
o
Light absorption in ethanol: Maximum at 2710A,£ =7000.
The melting point was undepressed on admixture with a 
specimen of authentic kojic acid supplied by Dr. A.H. Cook.
Attempted production of Aspergillic Acid on a Synthetic 
Medium.
The medium consisted of 1% DL-leucine, 1% PL-iso- 
leucine, 0-02% L-tryptophane and 0*5# sodium chloride.
The medium after sterilisation was water clear and had 
Pjj6*4. Inoculum and incubation were as described for 
production of aspergillic acid. After 14 days the only 
evidence of growth was a slight turbity of the culture 
solution. On working up as described for aspergillic 
acid there was no hydroxamic acid as evidenced by a 
negative ferric chloride test on the neutralised alkaline 
extract of the ether percolate.
Synthesis of 3-Hydroxy-2:5-di-iso-butylpyrazine.
DL-Leucine.
DL-Leucine was prepared from isohexanoic acid most 
conveniently by the method of Org. S^n., Vol.21, p.74.
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isoHexanoic acid (250g.) gave DL-leucine (90g., 32% theory) 
m.p.275-278° (sealed tube).
DL-Leucine Anhydride.
DL-Leucine (30g.) was heated under reflux with ethylene 
glycol (180ml.) on an oil bath. After 20 minutes solution 
was complete and heating was continued for a further 90 
minutes, the solution darkening slightly in colour. After 
standing 24 hours at 0° the solid was separated, washed 
with cold water (2 x 150ml.) and cold ethanol (2 x 150ml.) 
and dried over phosphoric oxide (Yield 14*6g., 38% theory) 
Crystallisation from ethanol gave DL-leucine anhydride as 
needles m.p.267-270°(sealed tube).
Found: C=63-5; H=9»70; N=12*7#
Calc, for C12H22°2N2: 0=65#7? H=9*73; N=12-4$
Fischer (Ber.>1901>34>433) gives m.p.271°(corr.) for DL- 
leucine anhydride prepared from DL-leucine ethyl ester.
3-Hydroxy-2:5-di-iso-butylpyrazine *
(a) DL-Leucine anhydride (5g.) was refluxed for 1 
hour with phosphoryl chloride (50ml.) in which it dissolved 
after a few minutes. The excess phosphoryl chloride was 
removed under reduced pressure from the red reaction 
solution. The semi-solid residue was treated with water 
(50ml.) and the mixture neutralised (litmus) with 2N-sodium 
hydroxide. The solution was extracted with ether (5x50ml.)
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and the combined extract was dried (calcium chloride) and
the ether evaporated. The residue partly crystallised,
the solid was separated (filtrate A) and washed with small
portions of chilled ether. Recrystallisation from
%
ethanol yielded 3-hydroxy-2:5-di-iso-butyrpyrazine as long 
needles m.p.144*5-147°. The yield was 700mg. at m.p.125-
143°.
Found: C=69*4; H=9-70; N=13-7#
C12H200N2 re<luires; C=69*2; H=9.62; N 13-5%
o
light absorption in ethanol: Maxima at 2290A,£ =6900;
o
3260A,£ =7600.
3-Hydroxy-2:5-di-iso-butylpyrazine was insoluble in water 
and sodium hydrogen carbonate solution but was soluble in 
3N-hydrochloric acid and in 3N-sodium hydroxide. It did 
not give a colouration with ferric chloride reagent and 
sublimed at 120°/0*01mm.
A mixture of 3-hydroxy-2:5-di-iso-butylpyrazine m.p.l44*5- 
147° with flavacol melted at 144-146*5°.
(b) Filtrate A.
The ether was removed and the residual oil distilled 
under reduced pressure. The distillate a colourless oil 
(2g.) was redistilled and the fraction b.p.H7-119°/4mm. 
was collected.
Found: C=59-7; H=7-62; N=ll-0; 01=21-15#
C12H19N2C1 reclulres; C=63 *6; H=8-4 ; N=12.*f; 01=15-7#
C12H18N2C12requires: C=55 *2; H=6-9; N=10.7; 01=27.22
The oil (l*5g.) was heated in an autoclave with an ethanolic 
solution of sodium ethoxide (from 0 -6g. sodium and 25ml. 
dry ethanol) for 4 hours at 180°. To the reaction mixture
water (50ml.) was added and the solution extracted with 
ether (3 x 20ml.). The ether extracts were combined, the 
solvent removed and the residual oil refluxed with 6N- 
hydrochloric acid (10ml.) for 24 hours. The solution was 
neutralised (litmus) with 3N-sodium hydroxide and extracted 
with ether (3 x 20ml.). The ether solution was dried 
(sodium sulphate), the solvent removed and the residue 
sublimed in high vacuum (100°/0*01mm.). The sublimate 
(250mg.) crystallised from aqueous ethanol to give 
3-hydroxy-2:5-di-iso-butylpyrazine as needles undepressed 
with a specimen described above.
No other identifiable product was isolated from this 
reaction.
Attempted Mixed Crystal formation between 3-Hydroxy-2:5- 
di-iso-but.vlpyrazine and 3-Hydroxy-2:5-di-sec. -butylpyrazine.
3-Hydroxy-2:5-di-isobutylpyrazine (4Qmg.) and 3-hydroxy- 
2 :5 -di-sec.-butylpyrazine (40mg.) were dissolved together 
in ethanol. Sufficient water was added to cause precipitation
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of ca.50# of the dissolved material,- the mixture was heated 
until totally dissolved and allowed to cool. The 
crystalline fraction which separated melted over the range 
100-130°. By addition of water to the mother liquor a 
second crop was obtained m.p.83-108°. Further crystallis­
ation of either of these crops did not give material of 
sharp melting point.
Reaction of Copper Chromite with Aspergillic Acid.
(cf. Butcher and Wintersteiner, J.Biol.Chem.,1944,135,359, 
Butcher, J.Biol.Chem.,1947,171,321).
Aspergillic acid (l*61g.) and copper chromite (3*22g. 
Org. Syn., Vol.19, p.31) were intimately mixed, heated at 
200° over 30 minutes and maintained at that temperature 
for 1 hour. A trace of sublimate formed on the cold 
surface of the vessel. The reaction mixture on cooling 
was extracted with ether (Soxhlet). The extract was 
grass-green in colour and from it separated on concentration 
to small bulk copper aspergillate (l*6g.) of m.p.200-202°. 
Butcher, lbc.cit. gives for aspergillic acid copper salt 
m.p.204-207°.
Beoxyaspergillic Acid.
(cf. Butcher and Wintersteiner, J.Biol.Chem.>1944,155.359. 
Butcher, J.Biol.Chem.,1947»171t321)
Aspergillic acid (2g.j m.p.85-92°) was dissolved in a
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solution of 100# hydrazine hydrate (2ml,) and ethanol 
(60ml*) and the mixture heated in an autoclave for 9 hours 
(until the reaction mixture gave no colouration with 
ferric chloride reagent) at 170°. The solution was 
evaporated to dryness in vacuo on a boiling water bath and 
the brown gummy residue dissolved in ether (100ml*) and 
filtered from insoluble material. The ether solution 
was extracted with 3N-hydrochloric acid (5 x 10ml.) and 
the acidic extract neutralised (litmus) with 3N-sodium 
hydroxide. The precipitate was filtered, dissolved in 
ether (100ml.) and extracted with 3N-sodium hydroxide 
(5 x 10ml.). The solution was neutralised (litmus) with 
3N-hydrochloric acid, the precipitate filtered, dried and 
sublimed at 100°/0»001 mm. The colourless sublimate 
(l*15g., 62# theory) m.p.91-96° crystallised from aqueous 
methanol to give deoxyaspergillic acid as irregular 
needles m.p.98-100°. It was not depressed in melting 
point on admixture with a specimen of deoxyaspergillic 
acid provided by Dr. 0. Wintersteiner.
Found: C*69*3*69*35; H=9*27,9*61; N=13»4# 
Calc, for C12H200N2s °=e9-2'’ H=9*62; N=13*5#
-»-21*30 (c,2*55; 1,1; in ethanol)
o
Light absorption in ethanol: Maxima at 2280A, £ =7500;
o
3250A, £ *±8000.
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Racemisation of Deoxyaspergillic Acid.
Deoxyaspergillic acid (260mg.; m.p. 9 3 - 9 7 ° , 21*2°) 
and N-potassium hydroxide (12*5211.) were heated together 
in an autoclave at 170° for 24 hours. The resulting 
solution was neutralised (litmus) with dilute hydrochloric
acid and the precipitate which separated was filtered.
Crystallisation from aqueous methanol gave racemic deoxy­
aspergillic acid as needles m.p.102-104°(180mg.). 
Recrystallisation from the same solvent did not cause 
further elevation of the melting point.
Found: C=69*0; H=9*57%
C12H200N2 re(luires: 0=69*2; H=9«62#
o
Light absorption in ethanol: Maxima at 2280A,£ =7000;
o
3250A,£ =8400.
r-Deoxyaspergillic acid gave 2*65 mole C-Methyl per mole 
(Kuhn-Roth). A mixture of r-deoxyaspergillic acid 
m.p.102-104° and deoxyaspergillic acid m.p.98-100° melted 
at 100-102°.
A mixture of r-deoxyaspergillic acid and 3-hydroxy-2(5)- 
iso-butyl-5(2)-sec.-butylpyrazine m.p.95-96° melted at
90-93°.
3-Hydroxy-2:5-di-sec.-butylpyrazine (80mg.) was treated 
with N-potassium hydroxide (4ml.) as detailed above. On 
working up as for racemic deoxyaspergillic acid starting 
material was recovered m.p.121-123°•
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A mixture of 3-hydroxy-2:5-di-sec♦-butylpyrazine m.p.122- 
123° and r-deoxyaspergillic acid melted at 80-85°.
Attempted Racemisation of Aspergillic Acid.
Aspergillic acid (300mg., m.p.95-96°, 13*0°)
was dissolved in N-potassium hydroxide (15ml.) and the 
solution autoclaved at 170° for 24 hours. The solution 
was filtered and adjusted to p^4 with 3N-hydrochloric acid. 
The aspergillic acid which separated was filtered, 
dissolved in hot aqueous ethanol and allowed to crystallise. 
The recovered aspergillic acid had m.p.91-94°.
+10*5 + 4° (c,l*15; 1»1» in ethanol)
Phenylazo-deoxyaspergillic Acid.
A solution of aniline (l*2ml.) in hydrochloric acid 
(10.5ml., S.G.1*19 and water 10*5ml.) was treated with 
saturated sodium nitrite solution below -3° until a 
positive test was given with starch-potassium iodide 
indicator. The resulting benzene diazonium chloride 
solution was added, dropwise with shaking, to deoxy­
aspergillic acid (700mg.) dissolved in ice-cold 3N-sodium 
hydroxide (35ml.). The yellow precipitate which formed 
was suspended in warm water (30ml.) and made just acid 
(congo red) with dilute hydrochloric acid with vigorous 
shaking. The product which separated was filtered,
-  OQ  -
dissolved in ethanol, warmed with charcoal and filtered.
To the hot alcoholic solution water was added until 
opaque. On standing phenylazo-deoxyaspergillic acid 
separated (870mg.; 8356 theory) a.p.183-187°. Crystallised 
from aqueous ethanol it separated as red needles m.p.188- 
190°(decomp.).
Found: 0=69-4; H=7-37; N=18-l,17-8# 
C18H240N4 re(*uires: C=69-2; H=7-69; N=17-95#.
The phenylazo-derivative of r-deoxyaspergillic acid was 
prepared as above (yield 75%) • Crystallised from aqueous 
ethanol it separated as red needles m.p.188-190°(decomp.).
Found: N=18*l#
C18H240N4 re(luireS! N=17*95%
Reduction of Phenylazo-deoxyaspergillic Acid.
A solution of phenylazo-deoxyaspergillic acid (82Qmg.) 
in ethanol (75ml.) was hydrogenated at ordinary pressure 
using platinic oxide catalyst (Org.Syn..Col.Vol.l.p.452: 
40mg.). The absorption of hydrogen ceased after 10 hours 
(203ml.corr.; 1*73 mol.). The catalyst was filtered and 
the residual yellow solution evaporated under reduced 
pressure leaving an orange coloured oil. On addition of 
a little aqueous alcohol and standing there separated a 
solid which was filtered and washed with a few drops of
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ethanol. The solid was dissolved in hot aqueous ethanol, 
treated with charcoal, and on standing there separated 
the product as orange needles m.p.138-14-0° (80mg.).
Found: C=63-9; H=9*01; N=18-8%
C12H250N3 re(iuires: C=63*4; H=11«0; N=18*5#
The product sublimed unchanged at 100°/0*01 nim.
Attempted oxidation of 3-Chloro-2:5-dimethylpyrazine to 
3-Chloro-pyrazine-2:5-dicarboxylic Acid.
To a stirred solution of 3-chloro-2:5-dimethyl- 
pyrazine (l*425g., 0*01 mole., prepared after Baxter and 
Spring, J.,1947,1179) in 3% potassium hydroxide (6ml.) 
at 70° was added a warm solution of potassium permanganate 
(6*32g., 0*04 mole.) in water (100ml*) by dropwise 
addition over 90 minutes. The mixture was maintained 
at 70° for 30 minutes with continued stirring. The 
residual permanganate was destroyed with sulphur dioxide. 
The manganese dioxide was filtered and the filtrate made 
acid (congo red) with dilute hydrochloric acid. The 
solution was cohcentrated in vacuo to about 20ml. and 
allowed to stand at 0°; there was no separation of solid. 
The solution was extracted with ether (5 x 20ml.) and the 
extract dried (sodium sulphate). On removal of the 
solvent there was no residue.
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Chromium Trioxide oxidation of Aspergillic Acid and 
Deoxyaspergillic Acid.
The glacial acetic acid used in these experiments was 
freed from oxidisable impurity by distillation from 
chromium trioxide.
(a) To a standard solution of chromium trioxide in 
glacial acetic acid (46ml., 11*05m.mole, available oxygen 
by iodine titration) in a flask fitted with reflux 
condenser was added a solution of aspergillic acid (lg.,
4*42m.mole.) in glacial acetic acid (20ml.). A heavy 
flocculent precipitate formed immediately. The flask was 
heated on a boiling water bath, the precipitate quickly 
dissolved and oxidation, as evidenced by the colour change, 
red to green, was rapid. After 20 minutes heating the 
solution was distilled under slight vacuum (ca.l5mm.) the 
first 12ml. being collected. To the distillate was added 
a few drops of a saturated solution of 2:4-dinitrophenyl- 
hydrazine in 3N-hydrochloric acid. On dilution with 
water and standing there separated a yellow solid which 
was filtered and dried over phosphoric oxide (42mg.). 
Crystallised from ethanol-water the product separated as 
orange platelets m.p.108-112°. A mixture with acetone
2:4-dinitrophenylhydrazone m.p.123-125° melted at 110-120°. 
A mixture of the product with methyl ethyl ketone 2:4- 
dinitrophenylhydrazone m.p.110-113° melted at 100-110°.
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(b) In another experiment using the same quantities 
as above, the oxidising agent was added over 20 minutes 
to the acetic acid solution of aspergillic acid at 100°, 
maintained under sufficient vacuum to give continuous 
distillation of 0*5ml./min. The distillate on treatment 
as before gave acetone 2:4-dinitrophenylhydrazone (5mg.).
In a duplicate experiment the yield was 7mg. of acetone 
2:4-dinitrophenylhydrazone from lg. aspergillic acid.
(c) To a solution of deoxyaspergillic acid (500mg.;
2*4m.mole.) in 80# aqueous acetic acid (25ml.) was added
a standard solution of chromium trioxide in glacial acetic 
acid (50ml.; 6m. mole., avail able oxygen by iodine titration). 
After standing overnight at room temperature there was no 
apparent change and the mixture was heated on a boiling 
water bath for 90 minutes. Under slight vacuum, 
distillate (3ml.) was collected. This distillate by 
treatment as described above gave a few mg. of yellow 
precipitate m.p.95-120°. Crystallised from aqueous 
ethanol the product separated as orange platelets m.p.103- 
118°. The product was undepressed on admixture with 
authentic acetone 2:4-dinitrophenylhydrazone.
Attempted conversion of Deoxyaspergillic Acid to a 
Chloropyrazine-derivative.
Deoxyaspergillic acid (lg.) was heated under reflux
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for 4 hours with phosphoryl chloride (10ml.)* Excess 
phosphoryl chloride was removed in vacuo and the residue 
dissolved in 3N-hydrochloric acid (20ml.). The solution 
was clarified by boiling with charcoal and on standing 
there separated a small quantity of crystalline material 
(ca. 5mg.). The solid was filtered (filtrate A) 
m.p. ca.200° with sintering above 150°. Sublimed at 
100°/0* 001mm. the product melted at 205° with sintering 
above 190°. There was not sufficient for analysis. 
Filtrate A was neutralised (litmus) with 3N-sodium 
hydroxide and the solid which separated was filtered and 
dried (640mg.) m.p.96-100°. The material gave a 
negative test (Lassaigne) for halogen and was undepressed 
in melting point on admixture with starting material.
Zinc Dust distillation of 3-Hydroxy-2:5-dimethylpyrazine.
3-Hydroxy-2:5-dimethylpyrazine (900mg.), zinc dust 
(lg.), zinc chloride (5g.) and sodium chloride (lg.) 
were finely ground and intimately mixed together. The 
mixture was heated in a distilling flask fitted with a 
receiver chilled in solid carbon dioxide. The flask 
was heated to 290° in 20 minutes, the mass sintering at 
220°. No volatile product was collected. On cooling 
the reaction mass was ground up with water (20ml.), made 
strongly alkaline with 50# potassium hydroxide, and
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steam distilled. Excess aqueous mercuric chloride was 
added to the distillate and the pale yellow flocculent 
precipitate which formed was filtered (200mg.). This 
solid was suspended in 50% potassium hydroxide (10ml.) 
and steam distilled. The distillate was treated with a 
few drops of methanolic picric acid and on standing there 
separated yellow rhombic crystals m.p.270-275°. The 
melting point was not depressed by admixture with ammonium 
picrate m.p.278-280°. Using zinc dust alone under 
similar conditions no identifiable product was isolated.
Deoxyaspergillic acid treated as detailed above 
either with zinc dust alone or with zinc dust, zinc 
chloride and sodium chloride mixture did not give any 
identifiable product.
N-Toluene-p-sulphonyltetrahydrodeoxyaspergillic Acid.
Adams platinic oxide catalyst (250mg., Org. Syn.,
Col.Vol.1, p.452) was suspended in glacial acetic acid 
(12<5ml.; distilled from chromium trioxide) and saturated 
with hydrogen at ordinary pressure at room temperature.
To this suspension was added a solution of deoxyaspergillic 
acid (l*42g.) in glacial acetic acid (25ml.). The 
mixture was shaken in an atmosphere of hydrogen the 
theoretical uptake being complete in 1 hour, and thereafter 
absorbtion was negligible. The catalyst was filtered
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and the acetic acid removed in vacuo. The residual oil 
was dissolved in pyridine (7ml.) and toluene-jo-sulphonyl 
chloride (2g.) was added and the mixture refluxed for 2 
hours. The reaction solution was poured into water and 
the oil which initially separated quickly solidified.
The product crystallised from aqueous ethanol as needles 
m.p.144-146°(l*14g.). From the mother liquors a second
crop m.p.128-132°(1*29g.; total yield 83% theory) was 
obtained by concentration. Recrystallised from aqueous 
ethanol N-toluene-p-sulphonyltetrahydrodeoxyaspergillic 
acid separated as needles m.p•146-148°. The compound
gave a positive test for sulphur (Lassaigne).
Found: C=62-3; H=8-26; F=7*36%.
C19H30°3N2S re(luires: C=62*3; H=8«20; N=7*57%*
Attempted hydrolysis of N-Toluene-p-sulphonyl-tetrahydro- 
deoxyaspergillic Acid.
(a) N-Toluene-£-sulphonyl-tetrahydrodeoxyaspergillic 
acid (lOOmg.) and N-sodium hydroxide (5ml.) were heated 
together under reflux for 4 hours. On cooling crystalline 
material (80mg.) separated and was identified as starting 
material.
(b) N-Toluene-g-sulphonyl-tetrahydrodeoxyaspergillic 
acid (200mg.) was heated in a sealed tube with 20% hydro­
chloric acid (8ml.) for 3 hours at 150°. On cooling a 
drop of oil separated from the clear acid solution and
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solidified. The solid was dissolved in hot ethanol 
and water added until opalescent. On cooling an almost 
colourless solid separated m.p.125-138°. A mixture 
with starting material m.p.146-148° melted at 134-142°.
(c) N-Toluene-g-sulphonyl-tetrahydrodeoxyaspergillic 
acid (200mg.) was heated in a sealed tube with concen­
trated hydrochloric acid (8ml.) for 3 hours at 150°.
On cooling an oily brown scum separated from the acid, 
it did not solidify and from it no identifiable product 
could be isolated. The aqueous phase was diluted to 
20ml. and neutralised with 3N-sodium hydroxide but on 
standing at 0° there was no separation of solid.
Conversion of Aspergillic Acid to the Biketopiperazine
(cf. Dutcher and Wintersteiner, J.Biol.Chem.,1944,155, 
359, Butcher, £.Biol.Chem.,1947,171,341).
To a solution of aspergillic acid (lg.) in 5N- 
hydrochloric acid (90ml.) was added at room temperature, 
over several hours, dropwise with shaking, saturated 
bromine water, until precipitation was complete. The 
separated solid was filtered and dried (750mg.; m.p.60° 
with initial softening). The solid was dissolved in 
glacial acetic acid (8ml.) and water (2ml.) added. To 
this solution under reflux, was added, over 4 hours,
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zinc dust (10g.). Boiling water (100ml.) was added to 
the reaction mixture and filtered at the boiling point.
The solid was extracted with boiling ethanol (100ml.) 
and the aqueous and alcoholic filtrates combined, con­
centrated to about 50ml. and allowed to stand at 0°.
The diketopiperazine separated as a colourless solid 
(270mg.). Crystallised from aqueous methanol the 
diketopiperazine crystallised as needles m.p.261-262° 
(sealed tube).
[o*]^ 10*7°(1,1; c,0*94, in methanol)
Butcher, loc.cit. gives m.p.249-250° (with sublimation) 
[cdD-KL3.8°.
Found: C=63*8; H=9*38; N=12*5#.
Calc, for C12H22°2N2: c=65#,7> H=9*73; N=12*4#.
The melting point was not depressed on admixture with 
DL-leucyl-DL-isoleucine anhydride m.p.273°. A mixture 
with DL-norleucyl-EL-isoleucine anhydride m.p.258-260° 
melted at 257-259°•
BL-Leucyl-DL-isoleucine anhydride and DL-norleucyl-DL- 
isoleucine anhydride were prepared by Mr. J.J. Gallagher.
Bromination of racemic Deoxyaspergillic Acid.
(cf. Dutcher, J.Biol.Chem.,1947,171,341).
Racemic deoxyaspergillic acid (l*lg.) was dissolved 
in glacial acetic acid (60ml.) and to this solution water
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(40ml.) was added. A solution of bromine (847mg.) in 
glacial acetic acid (10ml.) was added to the solution of r 
deco^aspergillic acid, in portions with shaking, at room 
temperature. The colour was discharged almost at once 
and after addition was complete the pale yellow solution 
was allowed to stand overnight at 0°. The solution was 
slightly opalescent and water was added until no further 
opalescence developed. On standing at 0° for several 
hours crude r-bromodeoxyaspergillic acid separated as a 
pale yellow solid. Filtered and dried over phosphoric 
oxide it had m.p.85° (with initial sintering), yield 
440mg. The aqueous filtrate was evaporated to dryness 
in vacuo leaving a brown solid residue. This residue 
was heated with water (100ml.) at the boiling point and 
filtered from insoluble solid. The filtrate was boiled 
with charcoal, filtered and re-evaporated to dryness 
under reduced pressure. Crystallised from aqueous 
ethanol the product separated as needles m.p.260-265° 
(130mg.). Recrystallised from the same solvent the 
m.p. was 266-268°(decomp.) not raised by further 
crystallisation. Lassaigne test for halogen on the 
product was negative.
o
Light absorption in ethanol: Maximum at 2860A;£ =21,000.
Dutcher, lffg.cit. gives m.p.268-270° for the quinone
o
Ct o0oNo and light absorption at 2850A,£=22,000.
12 lo 2 c.
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Reaction of Phosphoryl Chloride with the Diketopiperazine 
C12H22°2N2*
Diketopiperazine ^2^22^2^2^^’  ^ an(* P^osP^oryl 
chloride (25ml.) were heated under reflux for 1 hour, by 
which time evolution of hydrogen chloride had almost 
ceased. Excess phosphoryl chloride was removed in vacuo 
and the residue a red gum was treated with water (25ml.) 
and neutralised (litmus) with 3N-sodium hydroxide. The 
solution was extracted with ether (5 x 50ml.) and the 
combined extract shaken with 3N-sodium hydroxide (3 x 20ml.) 
The ether layer was retained (solution A). The alkaline 
extract was neutralised (litmus) with 3N-hydrochloric 
acid. The precipitate which separated was filtered, 
dried (700mg.) and sublimed at 80°/0*001mm. The sublimate 
crystallised from aqueous ethanol as irregular needles 
m.p.85-91°. The product gave a negative test for halogen 
(Lassaigne).
£ccjp^  + 12*2° (c,2*94; 1,1, in ethanol)
The product could not be purified to constant melting 
point by crystallisation and after several crystallisations 
from the same solvent melted over the range 94-100°.
The product was insoluble in water, soluble in 3N- 
sodium hydroxide, 3N-hydrochloric acid, ether, methanol 
and ethanol in the cold. The product was not depressed
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in melting point on admixture with deoxyaspergillic acid.
Solution A was washed with water and dried (sodium 
sulphate). The solvent was removed and the residual 
oil distilled under reduced pressure. The main fraction, 
a colourless oil (770mg.), was collected at 95-100°/lmm. 
and gave a positive test for halogen (Lassaigne).
Optical rotation of the oil in ethanol,
[kJ^+lS-V^c.T^; 1,1) ,+ 18*2° (c, 7 *29; 1,1)
The oil (0*75g.) and powdered potassium hydroxide (4g.) 
were heated together in an autoclave at 180° for 4 hours.
The reaction mixture was dissolved in water (20ml.) and 
neutralised (litmus) with 3N-hydrochloric acid. The 
solid which separated (250mg.) was sublimed at 80°/0#01mm. 
The sublimate, crystallised from aqueous ethanol as 
irregular needles m.p.70-90°, gave a negative test for 
halogen (Lassaigne). After several crystallisations 
from aqueous ethanol the product melted over the range 
90-100°. A mixture with the compound m.p.94-100°(above) 
melted over the range 90-100°.
DL-isoLeucine.
DL-isoLeucine was prepared by the malonic ester 
synthesis (Org. Syn., Vol.21, p.60) from sec.-butyl bromide, 
sec.-Butyl bromide (210g.? Org. Syn., Col.Vol.2, p.38) 
gave BL-isoleucine (45g., 23# theory) m.p.266-270°
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(sealed tube). A mixture with DL^leucine m.p.275-278° 
melted at 270-273°.
DL-isoLeucine Anhydride.
(a) (cf. Fischer, Ber.,1901,34,433, Dutcher, J.Biol.Chem., 
1947,171,341).
DL-isoLeucine (5*2g.) was suspended in refluxing 
ethanol (20ml.) and dry hydrogen chloride was passed 
through for 2 hours. The solvent was removed in vacuo 
and the syrupy residue dissolved in water (ca. 40ml.) 
and made alkaline (phenolphthalein) with 33% sodium 
hydroxide the temperature being kept below 10°. The
alkaline solution was extracted with ether (3 x 50ml.)
the extract dried (sodium sulphate) and the solvent 
removed. The residual oil was heated in a sealed tube 
at 180° for 2 hours. On cooling the crystalline mass 
was filtered, washed with a small portion of cold acetone 
and crystallised from aqueous methanol. DL-isoLeucine 
anhydride separated as needles m.p.280-283° (sealed tube, 
sintering above 270°).
Dutcher, lftc.cit. gives m.p.255-257
Found: C=63*4; H=9*62%.
Calc, for ci2H22°2N2s c=63#7; H=9*73#.
- 103 -
(b) (Sannie, Bull.Soc.Chim.,1942,9,487, cf. Baxter and 
Spring, £.,1947,1179).
DL-isoLeucine anhydride was prepared in 47% yield 
from DL-isoleucine and crystallised from aqueous ethanol 
as needles m.p.280-282° (sealed tube, sintering above 
270°). Baxter and Spring, loc.cit. give m.p.270-273° 
(sintering above 259°).
Found: C=63-6; H=10*05; N=12*l%.
Calc, for C12H22°2N2: C=63*7; H=9-73; N=12*4%.
A mixture of the diketopiperazine ci2H22°2N2 (;from 
aspergillic acid) m.p.261-262° and isoleucine anhydride 
melted intermediate between the melting points of the 
components as did a mixture with either DL-leucyl-DL- 
isoleucine anhydride or DL-norleucyl-DL-isoleucine 
anhydride. These last two compounds were prepared by 
Mr. <J. J. Gallagher.
Ninhydrin Reaction with cC-Amino-acids and derivatives 
of oL -Amino-acids.
The substances tabulated were tested under identical 
conditions as follows:-
The substance (5mg.) was dissolved or suspended in water 
(0 .5ml.) and ninhydrin reagent (3 drops; 0 *1% in ethanol) 
added. In all cases there was no colour development 
after 2 minutes in the cold. The specimens were immersed 
in boiling water giving the results indicated.
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- Indicates no colour,+ indicates intensity of colour.
Compound 30sec lmin ,1 *5min ► 2min 2 > 5min 5min .lOmin 20min.
DL-Alanine + + +++ +++++- +*4 4**t* +++++ Fading
DL-Leucine - + + + +++ Fading
DL-isoLeucine - +• ■f* 4*’+*+- + ++■■»• Fading
N-Formyl- 
DL-isoleucine - - - - - - - -
Dipeptide * - - - 4- 4-
DL-isoLeucine 
Anhydride - - - - - - - -
Diketopiperazine
C12H22°2R2 - - - - - - - -
Blank ** - - - - - - -
36 Dipeptide:- DL-Leucyl-DL-isoleucine anhydride 
3636 Blank:- Water (0*5ml.) and standard ninhydrin solution 
(3 drops).
After 40 minutes the dipeptide colouration completely faded.
Hydrolysis of isoLeucine anhydride.
(a) Alkaline Hydrolysis.
PL-isoLeucine anhydride (250mg.) was heated in a sealed 
tube with N-potassium hydroxide (25ml,) at 200° for 20 hours. 
The solution was neutralised (litmus) with dilute hydro­
chloric acid and concentrated to 10ml.. To the hot solution 
an equal volume of ethanol was added and on standing there 
separated needles m.p.266°. The product gave a positive
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ninhydrin reaction but could not be purified for analysis 
as after several recrystallisations from aqueous ethanol, 
it continued to give a positive test for ionic chlorine.
(b) Acid Hydrolysis.
(i) DL-isoLeucine anhydride (350mg.) was suspended 
in dry ethanol (25ml.) under reflux and dry hydrogen 
chloride was passed for 7 hours. The solvent was 
removed in vacuo, water (10ml.) added and re-evaporated. 
The residue was dissolved in water (50ml.) and the 
solution made just alkaline with ammonium hydroxide.
The ammoniacal solution was warmed and clarified (char­
coal), concentrated to 10ml. and an equal volume of 
ethanol added. On standing crystalline product 
separated as platelets sintering above 255°. The 
product gave a positive ninhydrin test but could not be 
freed from ammonium chloride by crystallisation.
(ii) DL-isoLeucine anhydride (500mg.) and hydriodic 
acid (5ml., S.G.1*5) were heated together under reflux
for 8 hours. The residual solution was evaporated to
»
dryness under reduced pressure* the residue dissolved 
in water (ca. 25ml.) and iodine removed by extraction 
with chloroform. The aqueous solution was treated with 
excess freshly precipitated silver hydroxide and 
filtered. The filtrate was desilvered by treatment 
with hydrogen sulphide and clarified (filteraid). The
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aqueous filtrate was evaporated to dryness leaving a 
powdery residue which separated from aqueous ethanol as 
scintillating plates m.p.263-266° (sintering above 250°).
Found: C=54*4; H=9*70; N=ll-4#.
Calc, for C12H24°3N2: C=59-0; H=9-84; N=ll-5#.
Calc, for C6H1502N2 : C=55-0; H=9*92; N=10-7#.
The hydrolysis product gave a strong positive reaction 
with ninhydrin reagent.
(iii) DL-isoLeucine anhydride (2g.) was refluxed 
with 48# hydrobromic acid (20ml.) for 20 hours. The 
reaction mixture was worked up as for (ii) above and 
gave on evaporation of the silver-free solution a white 
powder (l*25gO* Crystallised from aqueous ethanol the 
product separated as plates m.p.260-263°.
Found: 0=55*3; H=10*l; N=10*8#.
Calc, for C6H1302N: C=55-0; H=9*92; N:=10*7#.
The product gave a positive ninhydrin test.
The hydrolysis product (500mg.) was refluxed for 90
minutes with 98# formic acid (3ml.), the acid removed
in vacuo and the process repeated. The gummy residue
was treated with cold 0*5N-hydrochloric acid (2ml.) and
filtered. The product (300mg.) was crystallised from
boiling water from which N-formyl-DL-isoleucine separated
o
as platelets m.p.117-119 •
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Found: C=53-4; H=7*87; N=9-29#.
Calc, for C7H1303N: 0=52-8; H=8‘18; N=8-81#.
The melting point was undepressed on admixture with an 
authentic specimen.
Hydrolysis of the Diketopiperazine from Aspergillic Acid.
The diketopiperazine (5Q0mg.) and 48# hydrobromic 
acid (10ml.) were heated together under reflux for 12 
hours, the diketopiperazine slowly dissolving. The 
solution was evaporated to dryness under reduced pressure, 
a few ml. water added and re-evaporated to remove excess 
acid. The residue was dissolved in water (30ml.) and 
treated with excess freshly precipitated silver hydroxide. 
The silver bromide and silver hydroxide was filtered and 
the filtrate desilvered by passing hydrogen sulphide and 
filtering. The solution was evaporated to dryness, 
dissolved in water (10ml.) and the solution clarified 
with charcoal (lQmg.). The filtrate was evaporated to 
dryness leaving a white powder which was dried over 
phosphoric oxide (425mg.).
0 - l0 water)
The hydrolysate gave a positive ninhydrin reaction.
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Partition Chromatography of Diketopiperazine ^i2^22^2N2 
Hydrolysate on Paper.
(cf. Consden, Gordon and Martin, Biochem.J.,1944,38,224) 
The apparatus consisted of an inverted glass cylinder 
65cm. x 15cm. dia., with a close fitting ground glass 
base plate. The mobile phase reservoir was carried on 
a glass framework inside the cylinder and the paper strips 
were held in the reservoir by a microscope slide. The 
paper strips used were 8cm. broad, had an effective 
length of 60cm., and were nut from sheets of filter paper. 
The amino-acids were spotted along a horizontal line 
l*5cm. apart. n-Butanol saturated with water was used 
as the mobile phase and tests were allowed to run 24 
hours. The test-strips were then air-dried at 80°, 
wetted with a 0*1# solution of ninhydrin in n-butanol 
and redried at 80° for 5 minutes the new positions of 
the amino-acids being shown by purple stains. The amino- 
acids were used as 0*5# aqueous solution for spotting 
purposes. On strips on which the n-butanol front 
advanced 40cm. the respective distances advanced by 
amino acids were, glycine 1cm., DL-alanine 2*4cm.,
I-valine 7.9cm., DL-norvaline 9*6cm., DL-leucine, DL- 
isoleucine and DL-norleucine 12-13cm., C12H2202N2 hydro­
lysate 12-13cm.. A mixture of DL-leucine, DL-isoleucine 
and DL-norleucine showed as a single stain 12-13cm. from
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the origin under similar experimental conditions.
Preparation of N-3:5-dinitrobenzoyl-derivatives of 
DL-Deucine, DD-isoLeucine and DL-Norleucine.
(Saunders, Biochem.J.,1934,28,580)
The amino-acid (131mg., lm.mole.) was dissolved in 
0*5N-sodium hydroxide (4ml., 2m.mole.). To the solution 
was ad.ded powdered 3:5-dinitrobenzoyl chloride (231mg*, 
lm.mole.) and the mixture shaken vigorously for 2 minutes. 
The dinitrobenzoyl chloride dissolved giving an orange 
solution and after standing 1 hour was filtered from a 
small amount of insoluble matter, acidified with dilute 
hydrochloric acid and the precipitate filtered, water 
washed and crystallised from aqueous ethanol.
N-3:5-Dinitrobenzoyl-DL-leucine crystallised as pale 
yellow plates m.p.195-198° (sintering above 185°)
Found: 0=48*1; H=4*57; N=12*8#. 
C13H15°7N3 re(luires: C=48*0; H=4*62; N=12*9#.
Saunders, loc.cit., gives for N-3:5-dinitrobenzoyl-L- 
leucine m.p.186-187°.
N-^»5-Dintrobenzoyl-PL-isoleucine crystallised as small 
plates m.p.189-192° (sintering above 180°)
Found: 0=48*2; H=4*59; N=13*2#. 
C13H15°7N3 rec*uires: c=^8#0* H=4*62; N=12*9#.
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A mixture of N-3:5-dinitrobenzoyl-DL-leucine and N-3:5- 
dinitrobenzoyl-DL-isoleucine melted at 182-186°. 
N-3:5-Dinitrobenzoyl-DL-norleucine crystallised as 
aggregates of micro-plates m.p.202-204°
Found: C=47*6; H=4*87; N=12*9#. 
C13H15°7N3 re(luires: 0=48*0; H=4*62; N=12.9%.
A mixture of N-3:5-dinitrobenzoyl-DL-norleucine and 
N-3:5-dinitrobenzoyl-DL-isoleucine melted at 180-183° 
and with N-3:5-dinitrobenzoyl-DL-leucine melted at ISO- 
1860.
Degradation of DL-isoLeucine to Methyl Ethyl Acetaldehyde 
by Ninhydrin.
(cf♦ Schonberg, Moubasher and Mostafa, J.,1948,176; 
Uirtanen, Laine and Toivonen, Z.physiol.,Chem.,1940,266, 
193).
To a solution of DL-isoleucine (lOOmg.) in water 
(25ml.) contained in a 50ml. flask fitted with splash- 
head and condenser, was added ninhydrin (75mg.). Carbon 
dioxide was passed through the mixture and the issuing 
gas passed through a solution of 2:4-dinitrophenyl- 
hydrazine in 3N-hydrochloric acid (3ml.). The flask 
was heated on an oil bath and the reaction mixture became 
intense blue in colour. Heating was such that over 30 
minutes 10ml. of distillate was collected. From the
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distillate there separated methyl ethyl acetaldehyde 
2:4-dinitrophenylhydrazone as a yellow solid which was 
filtered and dried m.p.l23-126°(58mg.). Crystallised 
from ethanol the product separated as orange plates 
m.p.129-130°. Morgan and Hardy, Chem. & Ind..1933.52.
518, give for methyl ethyl acetaldehyde 2:4-dinitro- 
phenylhydrazone m.p.120*5°.
Methyl ethyl acetaldehyde was prepared by the method of 
Linstead and Mann, J.,1930,2069, and converted to its 
2:4-dinitrophenylhydrazone which crystallised from 
ethanol as orange plates m.p.127-129°.
Found: C=49*6; H=5*20; N=20*8#.
Calc, for C1]lH1404N4 : C=49*6; H=5*26; N=21-05#.
A mixture of this compound with the 2:4-dinitrophenyl- 
hydrazone of methyl ethyl acetaldehyde from DL-isoleucine 
melted without depression.
Degradation of DL-Leucine to isoValeraldehyde by Ninhydrin. 
(cf. Abderhalden, Z.physiol.Chem.,1938,252,87)
This was carried out as described for DL-isoleucine. 
isoValeraldehyde 2:4-dinitrophenylhydrazone crystallised 
from ethanol as orange plates m.p.123-125°.
Brady Analyst,1926,51,78 gives m.p.123°.
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Separation of Diketopiperazine Hydrolysate into DL- 
Leucine and isoLeucine (and alloisoLeucine).
(cf. Ehrlich, Ber. ,1904,37,1809, Brazier, Biochem. J. ,1930, 
24,1188).
The hydrolysate (425mg.) was dissolved in water 
(150ml.) and treated with a solution of cupric acetate 
(320mg.) in warm water (50ml.). After standing for 
several hours the precipitated copper salt was filtered 
(filtrate A), shaken with water (150ml.) and the 
suspension filtered. The solid was shaken with methanol 
(75ml.) and the mixture filtered. The solid was 
suspended in water and decomposed with hydrogen sulphide, 
the cupric sulphide filtered and the filtrate clarified 
(charcoal). The filtrate was evaporated to dryness and 
the residue crystallised from aqueous ethanol. DL- 
Leucine separated as plates (65mg.) m.p.270-273°.
Found: 0=54-5,54-9; H=9-82,9-48#.
Calc, for C6H1302N: C=55-0; H=9-92#.
The product was converted to its N-3:5-dinitrobenzoyl 
derivative as previously described for DL-leucine. The 
derivative crystallised from ethanol as plates m.p.194-
195-5°.
Found: 0=48.2,48.0; H=4"80,4«80; N=12.9,13*2% 
Calc, for C13% 507N5: C=48.0; H=4-62; N=12-9%
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The melting point was not depressed on admixture with 
N-3:5-dinitrobenzoyl-DL-leucine prepared from authentic 
DL-leucine and was depressed on admixture with either 
N-3:5-dinitrobenzoyl-DL-isoleucine or N-3:5-dinitro­
benzoyl -DL-norleucine .
In a repeat experiment the DL-leucine obtained by 
hydrolysis of the diketopiperazine ci2H22°2N2 was sukjected 
to Strecker degradation as described for authentic DL- 
leucine and the product characterised as its 2:4-dinitro- 
phenylhydrazone. The latter crystallised from ethanol 
as orange plates m.p.119-120°.
Found: C=49-6; H=5*05; N=21-3%.
Calc, for Ci:lH1404N4 : C=49-6; H=5-26; N=21‘05#*
This 2:4-dinitrophenylhydrazone was not depressed in 
melting point when admixed with isovaleraldehyde 2:4- 
dinitrophenylhydrazone. A mixture with methyl ethyl 
acetaldehyde 2:4-dinitrophenylhydrazone m.p.129-130° 
melted at 116-118°.
The filtrate A (p. 112 ) was evaporated to dryness and the 
residue extracted with warm methanol (2 x 30ml.). The 
methanolic filtrates were combined and the solvent 
removed in vacuo. The residue was suspended in water 
and the copper removed as sulphide with hydrogen sulphide. 
The solution was clarified (filteraid) and on evaporation
- 114 -
to dryness left a powdery residue (92mg.) m.p.250-253°•
Found: N=10-l, 10*2#.
Calc, for 012H1302N: N=9-9^.
The product (90mg.) was degraded with ninhydrin as 
described for DL-isoleucine and the aldehyde characterised 
as its 2:4-dinitrophenylhydrazone. The latter (80mg.) 
m.p.121° was twice recrystallised from ethanol, methyl 
ethyl acetaldehyde 2:4-dinitrophenylhydrazone separating 
as orange plates m.p.127-129°.
Found: C=49-4,49*7; H=5-00,4-91; N=20*9#. 
Calc, for C1]LH1404N4 : C=49*6; H=5-26; N=21-05#.
The product was not depressed in melting point on admixture 
with authentic methyl ethyl acetaldehyde 2:4-dinitrophenyl- 
hydrazone and was depressed in melting point on admixture 
with isovaleraldehyde 2:4-dinitrophenylhydrazone m.p.123- 
125° the mixture melting at 119-122°.
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SECTION II.
Glycine Amide.
(Yang and Rising, J.Amer.Chem.Soc.,1951,53,3183)
To glycine ethyl ester (51g., Fischer, Ber.,1901,34, 
435) was added a solution of ammonia in methanol (750ml. 
saturated at 0°). The mixed solution was held at 0° for 
48 hours, the solution concentrated under reduced pressure 
to 50ml. and filtered from glycine anhydride. The filtrate 
was evaporated to dryness under reduced pressure the oily 
residue quickly solidifying on standing. Crystallised 
from chloroform-ether, glycine amide separated m.p.62-64° 
(14g.). Concentration of the mother liquors gave a 
second crop (3*5g.) Yield 48#.
Yang and Rising, (J.Amer.Chem.Soc.,1931,55,3183), give 
m.p.67-68°.
D L -Alanine A m i d e .
EL-Alanine amide was prepared by the method above. 
DL-Alanine ethyl ester (19*8g.) gave DL-alanine amide 
m.p.63-67°(12g.,80* t h e o r y ) .
Yang and Rising, (J.Amer.Chem.Soc.,1931,53,3183) give 
m.p.71-72° for L-alanine amide.
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Attempted Condensation of ^ -Bromcinnamaldehyde with 
Glycine Amide and DL-Alanine Amide.
(a) Glycine amide (l*21g.) was added to a refluxing 
solution of ot-bromcinnamaldehyde (3*46g., Zincke and 
Hagen, Ber.,1884,17,1817) in absolute ethanol (50ml.) and 
heated for 30 minutes by which time the solution was dark 
red in colour. The solution was concentrated to half 
bulk but there was no separation of solid on standing. 
Removal of solvent under reduced pressure left a dark * 
viscous oil which could not be induced to crystallise.
The oil was dissolved in ethanol (10ml.) and a solution 
of sodium ethoxide in alcohol (0*5g.sodium in 20ml. dry 
ethanol) was added. The mixture was refluxed for 30 
minutes, sodium bromide separating. The alcohol was 
removed under reduced pressure, the residual tar 
dissolved in ether and the mixture acidified with 3N- 
hydrochloric acid. The acid layer was neutralised 
(litmus) with 3N-sodium hydroxide, ether extracted
( 3  x  2 0 m l . )  a n d  t h e  e x t r a c t  d r i e d  ( s o d i u m  s u l p h a t e ) .  
E v a p o r a t i o n  o f  t h e  s o l v e n t  l e f t  m e r e l y  a  t r a c e  o f  g u m .
(b) The same quantities of glycine amide and 
cA-bromcinnamaldehyde in ethanol (50ml.) were allowed to 
stand at room temperature for 2 days. The resulting 
solution was dark red in colour and on working up as
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described under (a) no product was isolated.
Using the same molecular proportions of DL-alanine 
amide and cC-bromcinnamaldehyde under the conditions 
described under (a) and (b) the reaction products were 
dark oils and from them no identifiable products were 
isolated on working up as above.
Attempted Condensation of DL-Alanine Ethyl Ester and 
o(-Bromcinnamaldehyde.
To a solution of o< -bromcinnamaldehyde (2*llg.) in 
dry ethanol (40ml.) under reflux was added-DL-alanine 
ethyl ester (1ml.). Heating was continued for 30 
minutes, the solution darkening in colour. The solvent 
was removed under reduced pressure leaving a dark oil 
which did not solidify. The oil was heated at 80-100° 
for 4 hours with liquid ammonia (5ml.) in an autoclave.
To the reaction mixture water (50ml.) was added and the 
mixture ether extracted (5 x 15ml.). The ether solution 
was extracted with 3N-hydrochloric acid (2 x 10ml.) and 
the extract neutralised (litmus). Extraction of the 
aqueous layer with ether and removal of the solvent left 
no residue.
Cinnamylidene—DL-alanine Amide.
C in n a m a l d e h y d e  (l*32g., l*2ml.) w a s  d i s s o l v e d  in
- 118 -
dry ethanol (40ml.) and to this solution under reflux 
Dl-alanine amide (880mg.) was added. The mixture was 
heated for 30 minutes, the solution concentrated to 15ml. 
and the resulting pale yellow liquid allowed to stand 
overnight at 0°. The separated solid was filtered and 
washed with a little ethanol m.p.150-153°. (Yield 920mg.). 
Recrystallised from aqueous ethanol cinnamylidene-DL- 
alanine amide separated as plates m.p.154-155°.
Found: C=71*l; H=6-87; N=14-4#. 
C12H140N2 re(iuires: C=71-3; H=6»93; N=13*9%.
Hydrolysis of Cinnamylidene-DL-alanine Amide.
To a saturated solution of cinnamylidene-DL-alanine 
amide in ethanol (2ml.) Brady’s Reagent (4 drops) was 
added. In a few seconds a voluminous red precipitate 
separated. After standing several hours the precipitate 
was filtered. Crystallised from acetic acid cinnam- 
aldehyde 2:4-dinitrophenylhydrazone separated as red 
micro-needles m.p.245° undepressed on admixture with an 
authentic specimen.
N - ( o c - B r o m p r o p i o n y l ) - t o l u e n e - p - s u l p h o n a m i d e .
( c f .  O p e n s h a w  a n d  S p r i n g ,  J . , 1945,234)
T o l u e n e - £ - s u l p h o n a m i d e  (20g.) a n d  o C - b r o m p r o p i o n y l  
b r o m i d e  (50g., 100# e x c e s s )  w e r e  h e a t e d  t o g e t h e r  a t  100°
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for 1 hour. The toluene-£-sulphonamide dissolved 
incompletely and on cooling the suspension was poured 
into cold water (500ml.). The mixture was shaken until 
the oil which separated solidified. The solid was 
water washed and ground up with excess of an aqueous 
suspension of sodium hydrogen carbonate. The unchanged 
toluene-£-sulphonamide and excess sodium hydrogen 
carbonate was filtered and the alkaline filtrate made 
just acid (litmus) with dilute hydrochloric acid. The 
solid which separated was filtered, and, crystallised 
from aqueous ethanol, N-(oc-brompropionyl)-toluene-£- 
sulphonamide separated as needles m.p.125-130° (27*6g., 
77# theory). The pure product obtained by recrystallis­
ation from aqueous ethanol had m.p.130-132°.
Equivalent weight by titration with sodium hydroxide 
(phenolphthalien) 309, 310: Theory, 306.
Abderhalden and Riesz (German Patent 539049) give 
for N-(<<-brompropionyl)-toluene-£-sulphonamide m.p.127°.
N - ( D L - A l a n y l ) - t o l u e n e - p - s u l p h o n a m i d e .
(a) Ammonium hydroxide (100ml., S.G., 0*88) was
added to N-(<X-brompropionyl)-toluene-£-sulphonamide
(lOg.) and the solution held, in a stoppered bottle, 
for 5 days at room temperature. The solution was 
evaporated under reduced pressure and the residue dis­
solved in water (50ml.). The solution on standing soon
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crystallised. The solid was filtered (7*5g*, 95# 
theory) and, crystallised from boiling water N-(DL- 
alanyl)-toluene-p-sulphonamide separated as needles 
m.p.234-235° (decomp., heated from 230°).
Found: N=ll*9#«
C10H14O3N2S requires: N=ll*6#.
(b) A solution of ethanolic ammonia was prepared 
by saturating ethanol with ammonia gas at -5°. This 
solution (20ml.) was added to N-(«(-brompropionyl)- 
toluene-£-sulphonamide (2g.) and the mixture held in a 
pressure vessel for 4 days at room temperature. The 
alcoholic ammonia was removed under reduced pressure 
and the residue dissolved in water (10ml.), from which 
solution on standing N-DL-alanyl-toluene-£-sulphonamide 
crystallised. Recrystallised from boiling water the
product separated as needles m.p.228°(decomp.) 
undepressed on admixture with a specimen prepared as 
above.
A m m o n o l y s i s  o f  N - ( o t - B r o m p r o p i o n y l ) - t o l u e n e - p - s u l p h o n a m i d e .
A mixture of N-(oC-brompropionyl)-toluene-£-sulphon- 
amide (lOg.) and liquid ammonia (20ml.) was heated at 
80° in an autoclave for 3 hours. The reaction mixture 
was diluted to 150ml. with water and the solid which 
separated was filtered m.p.137°(3g.). The melting point
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was not depressed on admixture with toiuene-£-sulphon- ' 
amide (m.p.138°). Evaporation of the mother liquor to 
50ml. gave a second crop (lg.) also identified as 
toluene-^-sulphonamide.
Attempted condensation of N-(DL-Alanyl)-toluene-p- 
sulphonamide and o(-Bromcinnamaldehyde.
N-(DL-Alanyl)-toluene-£-sulphonamide (l*2g.) was 
added to a solution of oC-bromcinnamaldehyde (l*05g.) in 
ethanol (40ml.). The suspension was autoclaved for 4 
hours at 100°. On cooling the undissolved solid was 
identified as starting material. Heating for a further 
period’ of 4 hours at this temperature caused no change. 
After 4 hours at 140° complete solution resulted but it 
was dark in colour. Evaporation of the solvent left an 
intractable tar which could not be induced to crystallise.
Glycine-hydroxamic Acid.
(cf. Jones and Sneed J.Amer.Chem.Soc.,1917,39,673)
To glycine methyl ester (12*5g., Fischer, Ber., 
1901,^4,433) was added methanolic hydroxylamine (3mole., 
Org.Syn.,Vol.26,p.74) and the mixture allowed to stand 
overnight at 0°. The glycine-hydroxamic acid which 
separated was filtered and dried.
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Condensation of Di-acetyl with Glycine-hydroxamic Acid.
Glycine-hydroxamic acid (l*9g.) was suspended in 
methanol (10ml.) and the suspension chilled in acetone- 
solid carbon dioxide. Di-acetyl (l*85g.) was dissolved 
in methanol (10ml.) and after similar pre-cooling was 
added to the suspension. To the resulting mixture 
5N-sodium hydroxide (5*3ml.) was added, dropwise with 
shaking, the cooling being maintained. The reaction 
solution was then held at 0° for several hours the 
glycine-hydroxamic acid dissolving to give a brown 
solution. After adjusting to p^4 by addition of dilute 
hydrochloric acid the solution was evaporated under 
reduced pressure. The residue was extracted with boiling 
chloroform (50ml.) and the chloroform evaporated. The 
resulting tar could not be induced to crystallise but, 
under high vacuum (100°/0*001mm.), gave a small quantity 
of pale yellow glassy sublimate. The sublimate 
liberated carbon dioxide from aqueous sodium hydrogen 
carbonate and, in ethanol solution, gave a claret colour­
ation with aqueous ferric chloride.
Condensation of Methyl-glyoxal and Glycine-hydroxamic Acid.
The reaction was carried out as above using glycine- 
hydroxamic acid (9g.)> methyl-glyoxal (7*2g.) and 
5N-sodium hydroxide (25ml.). On working up as described
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above a pale yellow glassy sublimate was obtained.
This sublimed product gave a positive ferric chloride 
reaction and liberated carbon dioxide from aqueous 
sodium hydrogen carbonate.
l-Hydroxy-2-keto-5-phenyl-l:2-dihydropyrazine.
Glycine-hydroxamic acid (3g«) was suspended in 
methanol (20ml.) and the suspension chilled with acetone 
and solid carbon dioxide. To this suspension was added 
a pre-cooled solution of phenyl-glyoxal hydrate (4*5g.) 
in aqueous methanol (15ml. methanol 5ml. water). To 
the resulting yellow suspension, 5N-sodium hydroxide 
(8«3ml.) was added at low temperature in portions with 
shaking. The mixture was allowed to warm to -5° over 
2 hours and held at that temperature overnight. After 
standing a further 2 hours at room temperature the 
suspension was held at 40° for 15 minutes and water 
(ca. 20ml.) added. The solution was cooled and on 
adjusting to pjj4 with dilute hydrochloric acid and 
standing, a semi-solid separated. This material, sub­
limed at 1 OO°/0*001mm., gave a yellow waxy solid (250mg.). 
Crystallised twice from methanol l-hydroxy-2-keto-5- . 
phenyl-1:2-dihydropyrazine separated as plates m.p.194- 
196°(decomp.).
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Found: C=63*9; H=4-15; N=15-l$.
C10H8°2N2 re(luires: 0=63*8; H=4*25; N=14*9$.
o
light absorption in ethanol: Maxima at 2700A,d=13,600;
o
3620A,d =5800.
l-Hydroxy-2-keto-5-phenyl-l:2-dihydropyrazine was 
slightly soluble in water, methanol and ethanol in the 
cold. It sublimed readily at 100°/0•001mm., liberated 
carbon dioxide from aqueous sodium hydrogen carbonate 
and gave a claret colouration, in ethanol solution with 
aqueous ferric chloride.
i
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